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ABSTRACT Natural	  killer	  (NK)	  cells	  are	  innate	  lymphocytes	  with	  a	  potent	  intrinsic	  capacity	  to	  kill	  tumor	  cells,	  which	  makes	  them	  attractive	  candidates	  for	  cell-­‐based	  cancer	  immunotherapy.	  Advances	  during	   the	  past	  decade	  have	  revealed	   that	  NK	  cells	  display	  a	  high	  degree	  of	  functional	  plasticity,	  suggesting	  that	  some	  subsets	  may	  be	  more	  effective	  in	  targeting	  cancer	  cells.	  In	  this	  thesis	  I	  have	  investigated	  the	  dynamic	  shaping	  of	  human	  NK	  cell	  repertoires	  with	  a	  focus	  on	  the	  biology	  and	  tumor	  killing	  potential	  of	  “adaptive”	  NK	  cells	  developing	  in	  response	  to	  human	  cytomegalovirus	  infection	  (HCMV).	  In	  the	  first	  part	  of	  this	  thesis	  we	  performed	  an	  in	  depth	  analysis	  of	  the	  NK	  cell	  killer	  immunoglobulin-­‐like	  receptor	  (KIR)	  repertoire	  in	  a	  cohort	  of	  204	  healthy	  individuals.	  We	  found	  a	  subset	  of	  NK	  cells	  that	  displayed	  evidence	  of	  clonal-­‐like	  expansion	  in	  HCMV	  seropositive	  individuals	  (referred	  to	  as	  adaptive	  or	  memory	  NK	   cells).	  These	   cells	  displayed	  a	  highly	  differentiated	  phenotype	   and	  distinct	  functional	  properties,	  characterized	  by	  a	  strong	  potential	  to	  perform	  antibody-­‐dependent	   cellular	   cytotoxicity	   (ADCC).	   Furthermore,	   these	   NK	   cells	   had	   a	  preferential	  expression	  of	  self-­‐specific	  KIRs.	  	  It	  is	  well	  established	  that	  the	  expression	  of	  KIR	  is	  genetically	  hardwired.	  In	  line	  with	   this,	   we	   found	   a	   linear	   correlation	   between	   KIR	   copy	   number	   variation	  (CNV)	   and	   the	   frequency	   of	   KIR	   expression.	   Although	   CNV	   had	   no	   effect	   on	  education	  at	  the	  single	  cell	  level,	  it	  influenced	  the	  overall	  size	  of	  the	  educated	  NK	  cell	   pool.	   However,	   KIR	   CNV	   had	   no	   effect	   on	   the	   frequency	   or	  magnitude	   of	  adaptive	  NK	  cell	  responses	  in	  HCMV	  seropositive	  individuals.	  A	  series	  of	  studies	  have	  linked	  the	  activating	  receptor	  NKG2C	  to	  the	  expansions	  observed	   in	   association	   to	   HCMV	   infection.	   To	   investigate	   whether	   other	  pathways	  could	  be	  involved	  in	  driving	  adaptive	  NK	  cell	  responses	  we	  analyzed	  NK	   cell	   repertoires	   in	   donors	   carrying	   a	   homozygous	   deletion	   of	   the	  NKG2C	  gene.	  We	  found	  that	  these	  individuals	  were	  fully	  capable	  of	  mounting	  adaptive	  NK	  cell	  responses	  and	  that	  CD2	  co-­‐stimulation	  of	  CD16	  signaling	  play	  a	  crucial	  role	   in	  NK	   cell-­‐mediated	  ADCC	  by	   adaptive	  NK	   cells,	   suggesting	   that	   CD2	   and	  CD16	   could	   compensate	   for	   the	   loss	   of	   NKG2C	   in	   the	   presence	   of	   HCMV	  antibodies.	  Furthermore,	  this	  indicated	  that,	  like	  the	  T	  cell	  activation	  model,	  NK	  cells	   also	   require	   multiple	   steps	   to	   become	   fully	   activated,	   where	   CD2	   co-­‐stimulation	  represents	  “signal-­‐2”.	  Based	  on	  the	  insights	  into	  the	  regulation	  of	  adaptive	  NK	  cells,	  we	  established	  a	  platform	   for	   selective	   expansion	   of	   this	   highly	   cytotoxic	   NK	   cell	   subset.	   We	  found	  that	  in	  vitro	  expanded,	  and	  functionally	  reprogrammed,	  adaptive	  NK	  cells	  showed	  potent	   and	   specific	   killing	  of	   primary	   acute	   lymphoid	   leukemia	   (ALL)	  blasts,	  suggesting	  that	  this	  strategy	  may	  be	  effective	  in	  the	  context	  of	  cell-­‐based	  cancer	  immunotherapy.	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1 INTRODUCTION 
 The	   first	  written	   description	   of	   the	   concept	   immunity	   is	   thought	   to	   be	   in	   430	   BC	   by	  Thucydides	   in	   Greece.	   This	   was	   when	   the	   plague	   hit	   Athens	   and	   the	   ones	   that	   had	  recovered	  from	  the	  disease	  were	  supposed	  to	  take	  care	  of	   the	   ill	  as	  “no	  one	  was	  ever	  attacked	  a	  second	  time”,	  at	  least	  not	  with	  a	  fatal	  outcome	  (1).	  Two	  of	  the	  true	  pioneers	  in	   immunology	   in	   the	  modern	   era	  were	   Ilya	  Mechnikov	   and	  Paul	   Ehrlich.	  Mechnikov	  discovered	  that	  certain	  cells	  could	  destroy	  pathogens	  by	  simply	  “eating	  them”,	  which	  is	  what	   we	   today	   refer	   to	   as	   phagocytosis.	   Ehrlich	   described	   the	   “side-­‐chain	   theory”,	   a	  description	   of	   how	   antibodies	   were	   formed.	   Although	   his	   theories	   were	   partially	  incorrect,	   based	   on	   them,	   he	   and	   other	   researchers	   could	   accomplish	   important	  groundwork	  in	  the	  immunology	  field	  (2).	  For	  these	  discoveries	  Mechnikov	  and	  Ehrlich	  were	   both	   awarded	   the	   Nobel	   Prize	   in	   1908.	   Today,	   we	   know	   that	   both	   principles	  represent	  important	  strategies	  for	  the	  immune	  system	  to	  eliminate	  invaders.	  	  	  The	   immune	  system	   is	   the	  bodies’	  defense	  against	   infections.	  However,	   the	   impact	  of	  the	  immune	  system	  goes	  beyond	  infectious	  diseases	  as	  it	  also	  protects	  us	  from	  tumors	  (3).	  Traditionally,	  the	  immune	  system	  is	  divided	  into	  the	  innate	  and	  adaptive	  immune	  system.	  Innate	  immunity	  is	  our	  first	  line	  of	  defense	  and	  mediates	  the	  initial	  response	  to	  pathogens.	   It	   plays	   a	   critical	   role	   in	   host	   defense	   as	   it	   can	   control	   and	   eliminate	  microbes	   directly	   or	   by	   shaping	   the	   adaptive	   immune	   system.	   The	   hallmark	   of	   the	  adaptive	  immunity	  is	  expansion	  and	  differentiation	  of	  lymphocytes	  that	  express	  unique	  rearranged	   receptors.	   The	   adaptive	   immune	   system	   provides	   a	   more	   specific	   and	  effective	  defense	  against	  pathogens	  including	  long	  lasting	  memory,	  which	  enables	  rapid	  and	  efficient	  response	  when	  re-­‐challenged	  with	  the	  same	  antigen	  (3).	  	  	  
1.1 BASIC CONCEPTS OF NK CELL BIOLOGY 
	  In	  the	  mid-­‐70’s	  Natural	  Killer	  (NK)	  cells	  were	  described	  for	  the	  first	  time	  by	  Kiessling	  et	  al.,	  at	  Karolinska	  Institutet	  simultaneously	  as	  Herberman	  et	  al.,	  at	  National	  Institute	  of	  Health.	   Many	   researchers	   had	   noticed	   a	   strange	   “background	   noise”	   in	   their	   T	   cell	  cytotoxic	   assays,	   consisting	   of	   a	   certain	   level	   of	   background	   killing	   of	   tumors	   not	  mediated	   by	   T	   cells.	   A	   closer	   investigation	   of	   this	   “background	   noise”	   led	   to	   the	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discovery	   of	   a	   new	   cell	   population.	   These	   cells	  were	   able	   to	   lyse	   target	   cells	  without	  prior	   sensitization	   and	  were	   therefore	   given	   the	   name	   natural	   killer	   cells	   (4-­‐7).	   Ten	  years	   after	   their	   discovery,	   a	   breakthrough	   in	   the	   understanding	   of	   the	   functional	  regulation	  of	  NK	  cells	  was	  presented	  by	  Klas	  Kärre	  in	  the	  postulation	  of	  the	  missing-­‐self	  hypothesis	  in	  his	  PhD	  thesis.	  At	  the	  time,	  NK	  cells	  were	  considered	  to	  work	  like	  T	  cells	  in	  terms	  of	   foreign	  antigen	   recognition,	  only	   that	   they	  did	  not	   seem	   to	  be	   influenced	  by	  MHC	   class	   I	   on	   the	   targets.	   An	   observed	   phenomenon	   of	   hybrid	   resistance,	   where	  (AxB)F1	   hosts	   reject	   A	   or	   B	   grafts	   from	   parental	   origin,	   contradicted	   the	   laws	   of	  transplantation	  at	   the	  time	  as	  the	  grafts	  did	  not	  express	  any	  foreign	  antigens	  (8).	  The	  insights	  provided	   in	   the	   “missing-­‐self”	  hypothesis	   led	   to	   a	   fundamental	   change	   in	   the	  view	  of	  NK	  cell	  function	  as	  it	  suggested	  that	  NK	  cells	  work	  though	  a	  completely	  different	  mechanism	  than	  T	  cells	  and	  sense	  targets	  absent	  of	  MHC	  class	  I	  molecules.	  In	  contrast	  to	  T	  cells,	  who	  lyse	  cells	  presenting	  non-­‐self	  peptides	  on	  their	  MHC	  class	  I	  molecules,	  NK	  cells	  work	  through	  the	  “missing	  self”	  phenomenon	  and	  kill	   targets	   that	   fail	   to	  express	  MHC	   class	   I	   on	   the	   cell	   surface	   (9)	   (Figure	  1).	   Together	  NK	   cells	   and	  T	   cells	  make	   a	  perfect	  complementary	  system,	  where	  infected	  cells	  trying	  to	  escape	  T	  cell	  immunity	  by	  downregulating	  MHC	  class	  I	  are	  eliminated	  by	  NK	  cells.	  	  
	  
Figure	  1.	  Missing	  self-­‐recognition	  by	  NK	  cells.	  MHC	  class	   I	   is	  expressed	  on	   the	  surface	  of	  all	  healthy	  cells	   and	   inhibits	  NK	   cell	   killing,	   preserving	   self	   tolerance.	   Upon	   virus	   infection	   or	   cell	   transformation,	  MHC	  class	   I	   is	  often	   reduced	  or	   lost	  and	  stress-­‐induced	   ligands	  are	  upregulated.	  Together	   these	  events	  lead	  to	  NK	  cell	  activation	  and	  killing	  of	  the	  infected	  or	  transformed	  cell.	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NK	  cells	  are	  considered	  as	  a	  part	  of	  the	  innate	  immune	  system	  as	  they,	  unlike	  T	  cells	  and	  B	   cells,	   do	  not	   rearrange	  genes	   to	   form	  diverse	   receptors	   for	   antigen	   specificity	   (10).	  The	  frequency	  of	  NK	  cells	  in	  peripheral	  blood	  range	  from	  5-­‐20%	  and	  they	  can	  be	  found	  in	  the	  bone	  marrow,	  lymphoid	  organs	  and	  many	  other	  tissues	  (11,	  12).	  NK	  cells	  play	  an	  important	  role	   in	  our	  defense	  against	  virus	   infected	  and	  transformed	  tumor	  cells	   (13,	  14).	  NK	  cells	  can	  also	  be	  found	  in	  the	  uterus	  and	  play	  an	  important	  role	  in	  implantation	  and	  pregnancy	  (15).	  	  	  In	  humans,	  NK	  cells	  are	  defined	  as	  CD3-­‐CD56+	  lymphocytes.	  They	  can	  further	  be	  divided	  into	  two	  subgroups	  based	  on	  CD56	  expression	  levels,	  CD56bright	  and	  CD56dim.	  CD56bright	  NK	  cells	  have	  an	  immunoregulatory	  function	  by	  secreting	  cytokines,	  while	  CD56dim	  NK	  cells	  represents	  the	  subset	  with	  cytotoxic	  function	  (16),	  albeit	  this	  functional	  dichotomy	  probably	  represent	  an	  oversimplification	  (17).	  Upon	  activation,	  NK	  cells	  can	  kill	  target	  cells	   via	   three	   different	   mechanisms:	   release	   of	   cytoplasmic	   granules	   containing	  perforin	  and	  granzymes	  upon	  direct	  recognition	  of	   target	  cells,	   induction	  of	  apoptosis	  through	   FAS/FAS-­‐L	   and	   TRAIL,	   or	   antibody	   dependent	   cellular	   cytotoxicity	   (ADCC)	  through	  the	  receptor	  CD16	  (18-­‐20).	  As	  we	  shall	  discuss	  below,	  recent	  progress	   in	   the	  NK	  cell	   field	  has	  revealed	  that	   the	  phenotypic	  and	  functional	  diversification	  of	   the	  NK	  cell	  repertoire	  extends	  beyond	  this	  simple	  division	  into	  two	  subsets	  with	  regulatory	  and	  cytotoxic	  roles,	  respectively.	  	  	  
1.2 NK CELL RECEPTORS 
	  
Killer-­‐cell	  immunoglobulin-­‐like	  receptors	  The	  ability	   of	  NK	   cells	   to	   sense	   cellular	   stress	   and	  kill	   targets	   that	   lose	   expression	  of	  MHC	  class	  I	  is	  tightly	  regulated	  by	  multiple	  activating	  and	  inhibitory	  signals.	  In	  humans	  the	   missing-­‐self	   response	   is	   determined	   by	   killer-­‐cell	   immunoglobulin-­‐like	   receptors	  (KIRs)	  (21,	  22).	  In	  mice	  the	  recognition	  of	  MHC	  class	  I	   is	  mediated	  via	  Ly49	  receptors	  (23).	   Although,	   both	   receptor	   families	   have	   developed	   to	   have	   similar	   function	   on	  regulation	  of	  NK	  cell	   function,	   they	  are	  structurally	  unrelated	  and	  therefore	  represent	  an	  elegant	  example	  of	  convergent	  evolution	  (24).	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The	   KIR	   locus	   is	   found	   on	   chromosome	   19	   and	   is	   part	   of	   the	   Leukocyte	   Receptor	  Complex	   (LRC)	   (25).	  The	  KIR	  nomenclature	   is	  based	  on	   the	   structure	  of	   the	   receptor	  proteins.	   The	   first	   parts	   of	   the	   name	   indicate	   whether	   the	   extracellular	   part	   of	   the	  receptor	  consists	  of	  two	  or	  three	  Ig-­‐like	  domains.	  The	  KIRs	  with	  short	  cytoplasmic	  tails	  (S)	  can	  generate	  activating	  signals	  via	  the	  interaction	  with	  the	  signaling	  molecule	  DAP-­‐12,	  containing	  immunoreceptor-­‐tyrosine-­‐based	  activating	  motifs	  (ITAM)	  (26).	  The	  KIRs	  with	   a	   long	   cytoplasmic	   tail	   (L)	   provides	   inhibitory	   signals	   via	   immunoreceptor	  tyrosine-­‐based	   inhibitory	   motifs	   (ITIM)	   associated	   in	   the	   cytoplasmic	   tail	   of	   the	  receptor	  (27).	  The	  natural	  ligands	  for	  inhibitory	  KIRs	  are	  specific	  allelic	  variants	  of	  HLA-­‐A,	  B	  and	  C,	  encoding	  for	  human	  MHC	  class	  I	  molecules	  (28).	  Among	  all	  KIRs	  expressed	  on	  NK	  cells,	   there	  are	  eight	  natural	   ligands	   identified.	  The	  most	  relevant	  ones	   for	   this	  thesis	  include	  HLA-­‐C	  allotypes	  with	  aspargine	  or	  lysine	  at	  position	  80	  (HLA-­‐C1	  or	  HLA-­‐C2),	  recognized	  by	  KIR2DL3	  and	  2DL1	  respectively	  (29).	  KIR3DL1	  senses	  HLA-­‐A	  and	  B	  with	  Bw4	  motifs	  at	  position	  77-­‐83	  (30)	  and	  3DL2	  can	  recognize	  HLA-­‐A3/A11	  and	  HLA-­‐F	  (31,	  32).	  The	  ligands	  for	  the	  activating	  KIRs	  are	  less	  well	  defined	  with	  the	  exception	  of	  KIR2DS1	  that	  binds	  to	  alleles	  carrying	  the	  HLA-­‐C2	  motif	  (29).	  More	  recently,	  there	  has	  also	   been	   evidence	   of	   3DS1	   binding	   to	   open	   conformers	   of	   HLA-­‐F	   (33).	   A	   detailed	  description	  of	  the	  KIRs	  and	  their	  cognate	  ligands	  can	  be	  found	  in	  Table	  1.	  	  	  Based	  on	  gene	  content,	  KIR	  haplotypes	  can	  be	  split	  into	  two	  groups,	  haplotype	  A	  and	  B.	  Haplotype	  A	  is	  the	  most	  common	  haplotype	  and	  contains	  only	  inhibitory	  genes	  except	  	  
KIR2DS4.	   Haplotype	   B	   individuals	   have	   more	   diverse	   gene	   content,	   including	   many	  additional	   inhibitory	   and	   activating	  KIRs	   not	   included	   in	   haplotype	  A	   (34).	   As	  we	   all	  have	  a	  double	   set	  of	   genes,	   the	  possible	  haplotypes	  are	  haplotype	  A/A,	  A/B	  and	  B/B.	  The	  two	  haplotypes	  can	  further	  be	  divided	  into	  centromeric	  and	  telomeric	  regions,	  Cen-­‐A,	  Tel-­‐A	  in	  haplotype	  A	  individuals	  and	  Cen-­‐B,	  Tel-­‐B	  in	  individuals	  with	  haplotype	  B	  (35,	  36).	   The	  KIR	   locus	   is	   divided	   by	   so-­‐called	   framework	   genes	   (3DL3,	   2DL4	   and	  3DL2),	  which	  are	  present	  in	  all	  individuals.	  The	  variable	  gene	  content	  between	  3DL3	  and	  2DL4	  are	   considered	   the	   centromeric	   region,	   whereas	   the	   genes	   between	   2DL4	   and	   3DL2	  represent	  the	  telomeric	  region	  (36).	  	  	  Although	   the	   frequency	   of	   haplotype	   A	   and	   B	   varies	   between	   different	   human	  populations	  (37,	  38),	  they	  are	  still	  maintained	  at	  significant	  frequencies,	  demonstrating	  their	   importance	   for	   survival	  on	  a	  population	  basis.	  While	   individuals	  with	  haplotype	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A/A	  and	  HLA-­‐C1	  have	  been	  associated	  with	  resistance	  to	  certain	  acute	  viral	  infections	  such	   as	   hepatitis	   C	   (HCV)	   and	   acute	   Ebola-­‐virus	   infection	   it	   is	   also	   a	   risk	   for	   pre-­‐clampsia,	  miscarriage	  and	   low	  birth	  weight	   if	   the	   fetus	   inherits	  paternal	  HLA-­‐C2	   (39-­‐41).	  The	  mechanism	  behind	  this	  is	  suggested	  to	  be	  due	  to	  inhibition	  of	  uterine	  NK	  cells	  expressing	  2DL1	  binding	  to	  HLA-­‐C2	  and	  therefore	  providing	  insufficient	  help	  to	  extra-­‐villous	   trophoblasts	   (EVT)	   leading	   to	   inadequate	   spiral	   artery	   formation.	   KIR	   B	  haplotypes	  can	  provide	  protection	  from	  these	  pregnancy	  disorders,	  particularly	  genes	  from	  the	  telomeric	  region	  where	  2DS1	  is	  found	  as	  it	  can	  counter	  the	  inhibitory	  effects	  of	  2DL1	  on	  the	  uterine	  NK	  cells	  (24).	  	  	  	  The	   influence	   of	   haplotype	   diversity	   is	   not	   only	   limited	   to	   pregnancies	   and	   acute	  infections.	  Several	  studies	  of	  allogeneic	  hematopoietic	  stem	  cell	  transplantation	  (HSCT)	  have	   shown	   that	   donors	   with	   haplotype	   B	   is	   associated	   with	   improved	   relapse	   free	  survival	  in	  AML	  patients	  as	  well	  as	  reduced	  relapse	  rate	  in	  pediatric	  ALL	  (42,	  43).	  The	  different	   advantages	   discussed	   above	   between	   the	   haplotypes	   demonstrate	   the	  importance	   of	   a	   variegated	   KIR	   repertoire	   for	   human	   survival	   in	   regards	   to	  reproduction,	  transplantation	  and	  infections.	  	  	  KIRs	  are	  stochastically	  expressed	  in	  a	  variegated	  manner	  and	  expression	  is	  determined	  by	  epigenetic	  regulations	  at	  the	  KIR	  gene	  promoter	  level	  (44,	  45).	  Further	  adding	  to	  the	  large	   diversity	   of	  KIR	   expression	   on	  NK	   cells	   is	   the	   extensive	  KIR	   gene	   copy	   number	  variation	  (CNV)	  (46).	  Paper	  II	  will	  discuss	  the	  effect	  of	  CNV	  on	  NK	  cell	  KIR	  repertoires	  and	  its	  influence	  on	  NK	  cell	  function.	  	  	  	  
NKG2-­‐family	  In	  addition	  to	  KIRs,	  NK	  cells	  also	  express	  NKG2A	  and	  NKG2C.	  They	  belong	  to	  the	  C-­‐type	  lectin	  receptors	  and	  are	   located	  on	  chromosome	  12	   in	   the	  gene	  cluster	  called	  natural	  killer	  complex	  (NKC)	  (47,	  48).	  NKG2A	  contain	  ITIMs	  in	  its	  cytoplasmic	  domain	  and	  acts	  as	  an	   inhibitory	   receptor	   (49),	  whereas	  NKG2C	   interacts	  with	  DAP12,	  which	  contains	  ITAMs	  and	  therefore	  acts	  as	  an	  activating	  receptor	  (50).	  Both	  NKG2A	  and	  NKG2C	  form	  heterodimers	  with	  CD94	  and	  binds	  to	  the	  non-­‐classical	  HLA-­‐E	  molecule	  (51).	  It	  appears	  that	  NK2GA	  has	  stronger	  affinity	  for	  HLA-­‐E	  and	  when	  both	  receptors	  are	  co-­‐expressed	  on	  the	  same	  NK	  cell,	  the	  inhibitory	  signals	  will	  overcome	  the	  activating	  signals	  (52,	  53).	  NKG2A	   expression	   is	   inversely	   expressed	   to	   KIR	   and	   has	   been	   proposed	   to	   serve	   a	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balancing	   role	   in	   the	   NK	   cell	   repertoire	   (45,	   54).	   NKG2C	   is	   associated	   with	   NK	   cell	  expansion	   in	  response	   to	  human	  cytomegalovirus	   (HCMV)	  (55,	  56),	  which	  will	  be	   the	  focus	   of	   paper	   I	   and	   III.	   However,	   approximately	   4%	   of	   the	   population	   in	   several	  ethnical	  groups	  harbor	  a	  homozygous	  deletion	  of	  the	  NKG2C	  gene	  (57-­‐59),	  suggesting	  that	  this	  receptor	  is	  not	  crucial	   for	  survival	  or	  reproduction.	  In	  paper	  III	  we	  assessed	  the	  impact	  of	  NKG2C	  gene	  deletion	  on	  the	  immune	  responses	  to	  HCMV	  infection.	  	  	  
Table	  1.	  NK	  cell	  receptors	  and	  their	  ligands	  
Receptors	   Ligands	  
Inhibitory	  receptors	   	  	  
KIR2DL1	   HLA-­‐Cw4	  
KIR2DL2/3	  	   HLA-­‐Cw3	  
KIR3DL1	   HLA-­‐Bw4	  
KIR3DL2	   HLA-­‐A3,	  HLA-­‐A11	  and	  HLA-­‐F	  
NKG2A	   HLA-­‐E	  
ILT2	  (LIR-­‐1)	  
HLA	  class	  I	  molecules,	  HLA-­‐G	  and	  HCMV-­‐encoded	  
UL18	  
Activating	  receptors	   	  	  
KIR2DS1	   HLA-­‐C	  
KIR2DS2	   n.d.	  
KIR2DS4	   HLA-­‐A11,	  some	  alleles	  of	  HLA-­‐C1	  and	  HLA-­‐C2	  
KIR3DS1	   HLA-­‐Bw4,	  HLA-­‐F	  
NKG2C	   HLA-­‐E	  
CD16	   IgG	  
DNAM-­‐1	   PVR	  and	  nectin-­‐2	  
NKp30	   B7-­‐H6,	  BAT-­‐3,	  HSPG	  
NKp40	   Hemaglutinin	  
NKp46	   Hemaglutinin,	  HSPG	  
NKG2D	   ULBP1-­‐4,	  MICA	  and	  MICB	  
CD2	   CD58	  (LFA-­‐3)	  
	  In	   addition	   to	   NKG2A	   and	   NKG2C,	   the	   NKG2-­‐receptor	   family	   also	   consists	   of	   the	  activating	   receptors	   NKG2D	   and	   NKG2E.	   NKG2D	   is	   expressed	   on	   most	   NK	   cells	   and	  unlike	   NKG2A/C/E,	   it	   forms	   a	   homodimer	   in	   its	   active	   form	   (60).	   NKG2D	   recognize	  stress-­‐induced	   ligands	   on	   transformed,	   virus-­‐infected	   or	   DNA	   damaged	   cells.	   These	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ligands	   include	   ULBP	   1-­‐4	   and	   MICA/B,	   suggesting	   an	   important	   role	   for	   NKG2D	   in	  tumor	  surveillance	  (61,	  62).	  	  The	  role	  for	  NKG2E	  in	  humans	  is	  still	  unclear.	  It	  has	  been	  shown	   that	   NKG2E	   can	   form	   heterodimers	   with	   CD94	   and	   signal	   through	   DAP12.	  However,	   it	   seems	   like	   this	   complex	   is	   retained	   intracellularly	   at	   the	   endoplasmic	  reticulum	  and	  not	  expressed	  on	  the	  cell	  surface	  (63).	  	  	  
Additional	  activating	  receptors	  NK	   cell	   function	   is	   balanced	   through	   numerous	   inhibitory	   and	   activating	   signals.	   To	  maintain	  tolerance	  to	  self,	  the	  inhibitory	  signals	  via	  KIRs	  and	  NKG2A	  dominate	  over	  the	  activating	   signals	   at	   steady	   state.	   The	   balance	   is	   shifted	   towards	   activation	   during	  cellular	   stress	   that	   cause	   loss	   of	   MHC	   class	   I	   and	   upregulation	   of	   stress-­‐associated	  ligands	  for	  activating	  receptors.	  Although	  activating	  receptors	  were	  described	  relatively	  recently,	  it	  is	  worth	  noting	  that	  the	  need	  for	  activating	  signals	  to	  trigger	  NK	  cell	  killing	  was	  predicted	  in	  the	  original	  description	  of	  the	  missing	  self	  hypothesis	  (64).	  One	  of	  the	  important	  activating	  receptor	  expressed	  on	  most	  CD56dim	  NK	  cells	  is	  CD16.	  CD16	  is	  the	  key	   receptor	   for	   NK	   cells	   to	   mediate	   ADCC	   (65).	   It	   binds	   to	   the	   Fc-­‐domain	   of	   IgG	  antibodies	  and	  its	  intracellular	  tail	  associates	  with	  FcRγ	  and	  CD3ζ,	  which	  both	  contain	  ITAM	   motifs,	   inducing	   an	   activating	   signal	   in	   NK	   cells	   (66).	   NK	   cell-­‐mediated	   ADCC	  triggered	  via	  antibodies	  secreted	  by	  B	  cells	  is	  just	  one	  example	  of	  the	  interplay	  between	  NK	  cells	  and	  the	  adaptive	  arm	  of	  the	  immune	  response.	  	  	  DNAM-­‐1	   is	   both	   an	   activating	   receptor	   and	   an	   adhesion	   molecule.	   It	   binds	   to	   PVR	  (CD155)	   and	   Nectin-­‐2	   (CD112),	   which	   are	   both	   stress	   induced	   ligands	   and	  overexpressed	  on	   tumor	   cells	   and	  CMV	   infected	   cells	   (67,	   68).	  DNAM-­‐1	  expression	   is	  correlated	  with	   the	   education	   status	   of	   the	   NK	   cells	   and	   has	   been	   shown	   to	   play	   an	  important	  role	  in	  both	  tumor	  surveillance	  and	  the	  formation	  of	  memory	  NK	  cells	  in	  mice	  (69,	  70).	  	  	  NKp30,	   NKp44	   and	   NKp46	   are	   all	   part	   of	   the	   natural	   cytotoxicity	   receptors	   (NCRs)	  family.	  NKp30	  and	  NKp46	  are	  expressed	  on	  almost	  all	  NK	  cells,	  while	  NKp44	  can	  only	  be	  detected	  on	  IL-­‐2-­‐activated	  NK	  cells	  (71,	  72).	  The	  ligands	  for	  NKp30	  and	  NKp44	  have	  been	  identified	  on	  tumor	  cells	  and	  NKp44	  and	  NKp46	  have	  been	  suggested	  to	  bind	  to	  hemaglutinin	  on	  influenza	  virus	  and	  therefore	  lyse	  cells	  infected	  with	  influenza	  (73,	  74).	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1.3 NK CELL EDUCATION 
	  Early	  studies	  of	  Ly49	  and	  KIR	  expression	  patterns	  suggested	  that	  all	  NK	  cells	  express	  at	  least	  one	  self-­‐KIR/Ly49,	  serving	  as	  a	  key	  mechanism	  to	  maintain	  tolerance	  to	  self	  (75).	  However,	   studies	   in	   beta-­‐2-­‐microglobulin	   (β2m)	   -­‐deficient	   mice	   lacking	   MHC	   class	   I	  molecules	   had	   normal	   frequencies	   of	   NK	   cells	   and	   instead	   of	   giving	   rise	   to	   auto	  reactivity,	  they	  were	  hyporesponsive	  (76).	  More	  recent	  investigations	  enabled	  through	  the	   development	   of	  multi-­‐parameter	   flow	   cytometry	   have	   revealed	   a	   relatively	   large	  subpopulation	   of	   NK	   cells	   lacking	   all	   known	   self-­‐specific	  MHC	   receptors	   in	  mice	   and	  humans	  (77,	  78).	  Similar	  to	  the	  findings	  in	  β2m-­‐deficient	  mice,	  such	  receptor-­‐negative	  NK	   cells	  were	  hyporesponsive.	   This	   demonstrated	   that	   regulation	   of	  NK	   cell	   function	  was	  much	  more	  complex	  and	  that	  NK	  cells	  lacking	  self-­‐Ly49/KIRs	  were	  able	  to	  exist	  in	  a	  hypofunctional	   state.	   The	   functional	   calibration	   of	   NK	   cells	   against	   their	   MHC	  environment	   was	   originally	   termed	   “licensing”	   by	   Kim	   et	   al.,	   who	   were	   the	   first	   to	  demonstrate	   that	   NK	   cells	   gained	   functional	   competence	   when	   inhibitory	   Ly49	  receptors	  recognized	  self-­‐MHC	  class	   I	  molecules	   (79).	  However,	  different	   terminology	  has	   been	   used	   to	   define	   this	   process	   and	   it	   will	   hereafter	   be	   referred	   to	   as	   NK	   cell	  education	  in	  this	  thesis	  (80,	  81).	  	  	  In	  human,	  NK	  cell	  education	  is	  based	  on	  the	  interaction	  between	  inhibitory	  KIRs	  (2DL1,	  2DL3,	  3DL1)	  and	  their	  cognate	  ligands.	  As	  the	  NK	  cells	  are	  inhibited	  in	  contact	  with	  self,	  they	   paradoxically	   become	  more	   responsive	   and	   “licensed”	   to	   kill	   target	   cells	   lacking	  self-­‐HLA	   (80).	   This	   process	   has	   also	   been	   observed	   for	   activating	   KIRs	   (2DS1).	   In	  contrast	  to	  inhibitory	  KIRs,	  the	  function	  of	  KIR2DS1+	  NK	  cells	  is	  down-­‐tuned	  in	  donors	  harboring	  the	  cognate	  ligand	  (HLA-­‐C2)	  (82).	  It	  has	  been	  shown	  that	  NK	  cell	  education	  can	  be	  highly	  dynamic	  over	  time	  as	  NK	  cells	  can	  become	  re-­‐educated	  when	  transferred	  to	   a	   new	   MHC	   environment.	   Adoptive	   transfer	   of	   uneducated	   NK	   cells	   from	   MHC-­‐deficient	   mice	   to	   MHC-­‐sufficient	   mice	   leads	   to	   acquisition	   of	   functional	   competence	  while	  transfer	  of	  educated	  NK	  cells	  to	  MHC-­‐deficient	  mice	  leads	  to	  induction	  of	  anergy	  (83,	  84).	  	  	  Although	  the	   functional	  phenotype	  of	  NK	  cell	  education	   is	  robustly	  established	  across	  species,	  a	  mechanistic	  explanation	  has	  still	  not	  been	  identified.	  Several	  models	  to	  define	  the	  NK	  cell	  education	  process	  have	  been	  suggested,	   including	  the	  “arming”	  model	  and	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the	  “disarming”	  model.	  The	  “arming”	  model	  suggests	  that	  the	  interaction	  between	  self-­‐specific	  MHC	  class	  I	  receptors	  and	  its	  cognate	  ligand	  induce	  positive	  signals	  resulting	  in	  functional	  maturation	  of	  precursor	  NK	  cells	  (85).	  The	  “disarming”	  model	  propose	  that	  NK	  cells	  lacking	  self-­‐specific	  MHC	  class	  I	  receptors	  become	  disarmed	  /	  hyporesponsive	  due	  to	  chronic	  stimulation	  during	  interactions	  with	  self-­‐cells	  (86).	  In	  addition	  to	  these	  two	  models,	  the	  “rheostat	  model”	  suggests	  that	  NK	  cell	  responsiveness	  is	  tuned,	  like	  a	  rheostat,	   by	   the	   net	   input	   from	   inhibitory	   receptors.	   The	   higher	   the	   inhibitory	   input	  during	  education,	  the	  more	  responsive	  the	  NK	  cell	  (87).	  	  	  	  
1.4 NK CELL DIFFERENTIATION 
	  NK	   cells	   develop	   from	  CD34+	   hematopoietic	   stem	   cells	   and	   hematopoietic	   progenitor	  cells	   (88).	   It	   has	   long	   been	   thought	   that	   NK	   cell	   maturation	   takes	   place	   in	   the	   bone	  marrow.	  However,	  NK	  cell	  precursors	  with	  potential	  to	  differentiate	  to	  mature	  NK	  cells,	  have	  been	  found	  to	  traffic	  to	  other	  peripheral	  tissues	  such	  as	  liver,	  tonsils	  and	  thymus.	  Caliguiri	  and	  colleagues	  have	  described	  early	  NK	  cell	  development	  in	  4	  stages.	  Stage	  1	  representing	  NK	  cell	  progenitors,	  stage	  2	  pre	  NK	  cells,	  stage	  3	   immature	  NK	  cells	  and	  stage	  4	  CD56bright	   NK	   cells.	   The	   final	   stage	   of	  maturation	  occurs	   during	   the	   transition	  from	  CD56bright	  to	  CD56dim	  NK	  cells	  (89).	  CD56dim	  NK	  cells	  have	  shorter	  telomeres	  than	  CD56bright,	   indicating	   that	   they	   have	   undergone	   more	   cell	   divisions.	   Furthermore,	  studies	  in	  vitro	  and	  in	  humanized	  mice	  have	  shown	  that	  CD56bright	  NK	  cells	  can	  acquire	  KIRs	  and	  CD16,	  gaining	  similar	  phenotypic	  properties	  as	  CD56dim	  NK	  cells	  (90).	  Notably,	  lineage	   tracing	   experiments	   hematopoiesis	   in	   macaques	   challenges	   the	   linear	  relationship	  between	  these	  two	  major	  NK	  cell	  subsets	  (91).	  	  Until	  recently,	  mature	  NK	  cells	  have	  been	  thought	  to	  be	  short-­‐lived	  lymphocytes	  with	  a	  static	  phenotype	  and	  a	  turnover	  rate	  around	  two	  weeks.	  However,	   in	  2010	  a	  series	  of	  papers	  were	   published	   indicating	   that	   the	   CD56dim	   NK	   cell	   subset	   was	  more	   diverse	  than	   previously	   anticipated	   (92-­‐95).	   Our	   group	   showed	   that	   the	   differentiation	   of	  CD56dim	  NK	  cells	  was	  associated	  with	  a	  decline	   in	  proliferative	  capacity	   together	  with	  changes	  in	  the	  expression	  of	  surface	  molecules	  crucial	  for	  NK	  cell	  activation	  and	  homing	  (92).	  NK	   cell	   differentiation	   could	  be	   traced	   in	   the	   gradual	   loss	   of	  NKG2A,	   sequential	  acquisition	  of	  KIRs	  and	  CD57	  (Figure	  2).	  These	  findings	  suggested	  that	  NK	  cells	  might	  not	   be	   as	   short-­‐lived	   as	   previously	   thought.	   Indeed,	   this	   notion	   is	   supported	   by	   the	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recent	  discovery	  of	  long-­‐lived	  “memory”	  or	  “adaptive”	  NK	  cells,	  which	  will	  be	  discussed	  in	  depth	  in	  this	  thesis.	  	  	  
	  
	  
Figure	  2.	  Overview	  of	  the	  NK	  cell	  differentiation	  process.	  As	  NK	  cells	  differentiate	  they	  become	  less	  proliferative	  and	  responsive	  to	  cytokines.	  They	  also	  gradually	  acquire	  KIRs	  and	  CD57,	  while	  losing	  NKG2A	  on	  the	  cell	  surface.	  
	  
	  
1.5 NK CELLS IN HEALTH AND DISEASE 	  
Cancer	  	  In	  1909,	  Paul	  Ehrlich	  proposed	  the	  concept	  of	  cancer	   immunosurveillance,	  suggesting	  that	   the	   immune	   system	   continuously	   eradicate	   arising	   tumors	   preventing	   the	  occurrence	   of	   cancer	   (96).	   After	   many	   decades	   of	   disbelief,	   a	   role	   for	   the	   immune	  system	   in	   cancer	   surveillance	   was	   established	   through	   the	   observation	   of	   higher	  susceptibility	  to	  chemically-­‐induced	  tumors	  in	  immunodeficient	  mice	  (97).	  This	  finding	  marked	  a	  new	  era	  of	  optimism,	  as	  the	  immune	  system’s	  potential	  in	  controlling	  cancer	  was	  unmasked.	  Increasing	  interest	  in	  this	  area	  has	  now,	  15	  years	  later,	  culminated	  in	  a	  clinical	   breakthrough	   for	   cancer	   immunotherapy.	   The	   interplay	   between	   the	   immune	  system	  and	   the	   tumor	   is	   termed	   immunoediting,	  which	   consists	   of	   three	  phases.	   The	  first	  phase	  is	  the	  previously	  described	  immunosurveillance	  where	  immunogenic	  tumors	  are	  eradicated.	  This	   is	   followed	  by	   the	   second	  phase,	   the	  equilibrium	  phase,	  which	   is	  characterized	  by	  the	  co-­‐existence	  of	  tumor	  and	  immune	  cells	  and	  thus	  tumor	  cells	  will	  be	   phenotypically	   shaped	   by	   the	   immune	   system.	   Due	   to	   selective	   immune	   pressure	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during	   the	   equilibrium	   phase,	   an	   outgrowth	   of	   non-­‐immunogenic	   tumors	   will	   occur,	  leading	   to	   the	   last	   phase,	   the	   escape	   phase,	  where	   tumors	  manage	   to	   evade	   immune	  control.	  	  	  The	   role	   of	   NK	   cells	   in	   immunosurveillance	   was	   revealed	   when	   using	   RAG2-­‐/-­‐	   mice	  (lacking	   adaptive	   immunity)	   versus	   RAG2-­‐/-­‐x	   [gamma]c-­‐/-­‐	   mice	   (lacking	   adaptive	  immunity	   and	   NK	   cells).	   Methylcholanthrene	   (MCA)–induced	   sarcomagenesis	   was	  compared	  in	  the	  two	  immunodeficient	  mice,	  resulting	  in	  higher	  incident	  of	  sarcoma	  in	  the	  RAG2-­‐/-­‐x	  [gamma]c-­‐/-­‐	  mice.	  These	  results	  were	  the	  first	  to	  show	  that	  NK	  cells,	  in	  the	  absence	  of	  adaptive	  immunity	  could	  control	  tumors	  (98).	  By	  gaining	  new	  insights	  into	  how	  the	  immune	  system	  can	  control	  or	  eliminate	  tumors	  and	  how	  tumors	  can	  evade	  the	  immune	  system	  we	  may	  be	  able	  to	  develop	  new	  therapeutic	  strategies	  targeting	  cancer	  diseases.	  Paper	   IV	   will	   further	   discuss	  NK	   cell	  mediated	   therapy	   in	   cancers	   using	   in	  
vitro	  expanded	  NK	  cells.	  	  	  
Viral	  infections	  NK	   cells	   can	   contribute	   to	   the	   control	   of	   virus	   infections	   by	   directly	   eliminating	   the	  virus-­‐infected	  cells	  or	  by	  modulating	  the	  adaptive	  immune	  system.	  Patients	  with	  NK	  cell	  deficiencies	  have	  shown	  to	  be	  affected	  by	  severe	  viral	   infections	  during	   life	  (99,	  100).	  However,	   many	   viruses	   are	   co-­‐evolving	   with	   us	   and	   have	   found	   ways	   to	   escape	   the	  elimination	  by	  immune	  cells,	  resulting	  in	  latency.	  An	  example	  of	  this	  is	  the	  herpesvirus	  family	   where	   HCMV	   is	   a	   member	   (101,	   102).	   T	   cells	   are	   considered	   to	   be	   the	   most	  important	   player	   in	   controlling	  HCMV	   infection	   (103).	   To	   escape	   from	  T	   cell	   antigen	  recognition	   many	   viruses,	   including	   HCMV,	   downregulate	   MHC	   class	   I	   on	   their	   cell	  surface	  (104).	  As	   this	   instead	  will	   lead	   to	  recognition	  by	  NK	  cells,	   the	  viruses	  have	   to	  evolve	   further	  mechanisms	   to	   stay	  undetected	   in	  order	   to	   escape	  NK	   cell	   elimination	  (105).	  To	  inhibit	  NK	  cell	  activation	  and	  cytotoxicity,	  HCMV	  has	  evolved	  the	  MHC	  class	  I	  homologue	   UL18	   glycoprotein	   (gpU18).	   gpU18	   is	   recognized	   by	   LIR-­‐1,	   an	   inhibitory	  receptor	  on	  NK	  cells.	  During	  the	  late	  phase	  of	  HCMV	  infection	  when	  endogenous	  MHC	  class	  I	  is	  downregulated,	  gpU18	  has	  been	  seen	  to	  be	  expressed	  in	  abundance	  (106).	  In	  addition	   to	   gpU18,	   the	   signal	   peptide	   of	   the	   CMV	   UL40	   protein	   promotes	   surface	  expression	  of	  HLA-­‐E,	   inhibiting	  NK	  cells	  via	  NKG2A/HLA-­‐E	  interaction	  (107).	  This	  has	  led	   to	   further	   imprints	   in	   the	   NK	   cell	   receptor	   repertoire,	   where	   an	   expansion	   of	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NKG2C+	  NK	  cells	  can	  be	  observed	  following	  HCMV	  infection	  (55,	  108).	  The	  imprints	  of	  HCMV	  on	  NK	  cell	  repertoires	  will	  be	  further	  discussed	  in	  papers	  I	  and	  III.	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2 AIMS 	  
The	  overall	  aim	  of	  this	  thesis	  was	  to	  delineate	  the	  biology	  of	  adaptive	  NK	  cells	  with	  the	  ultimate	  goal	  of	  harnessing	  their	  tumor-­‐killing	  potential	  in	  cancer	  immunotherapy.	  	  	  
Paper	   I.	   Expansion	   of	   NK	   cells	   expressing	   NKG2C	   has	   been	   associated	   with	   HCMV	  infection.	  In	  paper	  I	  we	  explored	  the	  influence	  of	  HCMV	  on	  NK	  cell	  KIR	  repertoires	  in	  a	  large	  cohort	  of	  individuals	  and	  addressed	  whether	  fluctuations	  in	  KIR	  expression	  could	  be	  used	  to	  trace	  NK	  cell	  adaptation	  to	  virus	  infections.	  	  
Paper	  II.	  KIR	  expression	  is	  stochastically	  distributed	  on	  NK	  cells	  and	  genetically	  hard-­‐wired.	  NK	   cell	   function	   is	   tuned	  by	  HLA-­‐KIR	   interactions	   and	  KIR	   gene	   copy	  number	  variation	  has	  been	  suggested	  to	  influence	  antiviral	  immunity.	  The	  aim	  of	  this	  paper	  was	  to	  study	  the	  effect	  of	  KIR	  gene	  copy	  number	  variation	  on	  the	  expression	  of	  KIRs	  and	  its	  influence	  on	  NK	  cell	  education.	  	  	  
Paper	  III.	  NK	  cell	  expansions	  have	  been	  seen	  to	  occur	  in	  the	  absence	  of	  NKG2C	  in	  HCMV	  seropositive	  individuals.	  In	  paper	  II	  we	  searched	  for	  other	  potential	  drivers	  of	  adaptive	  NK	  cells	  in	  the	  absence	  of	  NKG2C	  in	  a	  cohort	  of	  individuals	  lacking	  the	  NKG2C	  gene.	  	  	  
Paper	   IV.	   Educated	   NK	   cells	   are	   more	   functional	   upon	   stimulation	   with	   HLA	  mismatched	   targets	   compared	   to	   uneducated	   NK	   cells.	   As	   shown	   in	   paper	   I	   and	   III,	  expansion	   of	   NK	   cells	   expressing	   one	   single	   self-­‐KIR	   occurs	   naturally	   in	   some	  HCMV	  seropositive	  individuals.	  The	  aim	  of	  this	  paper	  was	  to	  generate	  a	  robust	  platform	  for	  in	  
vitro	   expansion	  of	   educated	  NK	  cells	   and	   test	   their	   efficacy	  against	   a	  panel	  of	  NK	  cell	  resistant	  ALL	  blasts.	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3 RESULTS AND DISCUSSION 	  
3.1 NK CELL RECEPTOR REPERTOIRE PLASTICITY 
	  
Adaptive	  features	  of	  innate	  immune	  responses	  to	  virus	  infections	  The	  human	   immune	  system	  is	  highly	  diverse	  and	  unique	  to	  each	   individual.	  Although	  genetics	  play	  a	  role	  in	  the	  formation	  of	  our	  immune	  systems,	  recent	  twin	  studies	  have	  indicated	   that	   non-­‐heritable	   factors	   contribute	   much	   more	   than	   heritable	   factors.	  Comparisons	  of	  immune	  parameters	  in	  healthy	  genetically	  identical	  twins	  revealed	  that	  they	   were	   more	   diverse	   in	   older	   than	   younger	   twins	   (109).	   This	   suggests	   that	   the	  heritable	   factors	   that	   shape	   our	   immune	   systems	   are	   overshadowed	   by	   cumulative	  influence	  of	  environmental	  factors	  as	  we	  get	  older.	  Traditionally,	  the	  immune	  system	  is	  divided	  into	  the	  innate	  and	  adaptive	  arms	  where	  the	  hallmark	  of	  adaptive	  immunity	  is	  the	   ability	   to	   generate	   a	   specific	   “adapted”	   response	   to	   a	   wide	   range	   of	   antigens.	  However,	   the	   growing	   evidence	   of	   adaptive-­‐like	   behavior	   of	   several	   cell	   types,	  traditionally	   classified	  within	   the	   innate	   immune	   system,	   challenges	   the	   concept	   of	   a	  strict	  border	  between	  innate	  and	  adaptive	  immunity	  (110,	  111).	  	  	  Recent	   insights	   into	   NK	   cell	   biology	   have	   demonstrated	   that	   NK	   cell	   phenotype	   and	  function	  are	  more	  dynamic	  than	  previously	  thought.	  Studies	  of	  NK	  cells	  in	  CMV	  infected	  mice	  demonstrated	  an	  accumulation	  of	  NK	  cells	  expressing	  the	  receptor	  Ly49H,	  which	  binds	  to	   the	  mouse	  CMV	  (MCMV)	  encoded	  MHC	  class	   I	  homolog	  m157	  (112,	  113).	  To	  study	  the	  kinetics	  of	  this	  subset,	  Ly49H+	  NK	  cells	  were	  transferred	  to	  DAP12-­‐deficient	  mice	   (which	   are	   deficient	   in	   Ly49H	   receptor	   expression	   and	   function).	   Shortly	   after	  MCMV	  infection,	  an	  expansion	  of	  Ly49H+	  NK	  cells	  was	  observed	  in	  the	  mice.	  The	  rapid	  expansion	  of	   the	  Ly49H+	  NK	  cells	  peaked	  at	  day	  7	  and	  was	   followed	  by	  a	  contraction	  phase	  (demonstrated	  by	  a	  decline	  of	  Ly49H+	  NK	  cell	  frequency)	  before	  forming	  a	  small	  pool	  of	   long-­‐lived	  memory-­‐like	  NK	  cells	  with	  heightened	  responses	  to	  re-­‐challenge	  by	  the	  same	  antigen	  (113).	  These	  data	  revealed,	   that	   in	  response	   to	  MCMV	   infection,	  NK	  cells	   displayed	   dynamics	   mimicking	   the	   formation	   of	   memory	   CD8+	   T	   cells	   which	  contain	   the	   same	   three	   phases:	   expansion,	   contraction	   and	   memory	   pool	   formation	  (114).	  In	  addition	  to	  Ly49H+	  NK	  cells,	  a	  subset	  of	  hepatic	  NK	  cells	  have	  been	  observed	  to	  acquire	  antigen-­‐specific	  memory	  of	  several	  structurally	  different	  viral	  antigens	  and	  that	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this	   process	  was	   dependent	   on	   the	   chemokine	   receptor	   CXCR6.	   This	  memory	   subset	  differed	  phenotypically	   from	   the	  MCMV	   induced	  Ly49H+	  memory	  NK	   cells,	   indicating	  that	  it	  is	  a	  separate	  subset.	  In	  this	  study	  by	  Paust	  et	  al.,	  they	  show	  that	  adoptive	  transfer	  of	   virus-­‐sensitized	   hepatic	   NK	   cells	   expressing	   CXCR6	   to	   naïve	   Rag2-­‐/-­‐Il2rg-­‐/-­‐	   mice	  recipient	   mice	   could	   provide	   protection	   against	   lethal	   challenge	   with	   the	   sensitizing	  virus,	  as	  they	  survived	  longer	  than	  the	  naïve	  mice	  (115).	  However,	  to	  date,	  we	  still	  lack	  mechanistic	  explanations	  for	  these	  observed	  “memory”	  NK	  cell	  expansions.	  	  Similar	   to	   the	   observations	   of	   Ly49H+	   NK	   cell	   expansion	   in	   mice	   following	   MCMV	  infection,	   accumulation	   of	   NK	   cells	   expressing	  NKG2C	   has	   been	   associated	  with	   CMV	  infection	  in	  humans.	  Guma	  and	  colleagues	  have	  demonstrated	  that	  in	  vitro	  cultures	  with	  HCMV	   infected	   fibroblasts	   can	   trigger	   the	   expansion	  of	  NKG2C+	  NK	   cells	  whereas	  NK	  cell	   cultures	   blocking	   the	   NKG2C	   receptor	   inhibited	   the	   expansion	   (56).	   As	   HCMV	  infection	  usually	  presents	  with	  subclinical	  symptoms	  followed	  by	  life-­‐long	  latency,	  it	  is	  difficult	  to	  study	  the	  initial	  NK	  cell	  responses	  directly	  after	  exposure.	  However,	  HCMV	  is	  an	   opportunistic	   infection	   and	   many	   patients	   undergoing	   HSCT	   with	   suppressed	  immune	  responses	  will	  face	  re-­‐activation	  of	  the	  virus.	  This	  enables	  interrogation	  of	  NK	  cell	   responses	   in	   the	   acute	   phase	   of	   HCMV	   infection.	   Recent	   studies	   of	   the	   NK	   cell	  receptor	   repertoire	   in	  HSCT	  patients	  with	  CMV	  reactivation	  reveal	   that	   in	  addition	   to	  the	  expansion	  of	  NK	  cells	  expressing	  NKG2C,	  these	  cells	  also	  displayed	  a	  more	  mature	  phenotype	  characterized	  by	  NKG2A-­‐CD57+KIR+	  and	  were	  found	  to	  persist	  over	  one	  year	  in	  the	  recipient	  (116).	  This	  demonstrates	  that	  long	  lasting	  NK	  cells	  adapting	  to	  CMV	  can	  be	  found	  in	  both	  mice	  and	  humans,	  albeit	  they	  differ	  in	  many	  characteristics	  (Table	  2).	  In	  contrast	  to	  memory	  NK	  cells	  in	  mice,	  no	  evidence	  of	  antigen-­‐specific	  memory	  NK	  cells	  in	  human	  have	  been	  found	  so	  far	  and	  it	   is	  unclear	  how	  HCMV	  drives	  the	  expansion	  of	  NKG2C+	   NK	   cells.	   The	   main	   focus	   of	   this	   thesis	   is	   to	   discuss	   the	   “adaptive”	   NK	   cell	  responses	   in	  human.	   In	  paper	  I	  we	  aimed	  to	  study	  viral	   imprints	  on	  NK	  cell	  receptor	  repertoires	  in	  a	  large	  cohort	  of	  healthy	  individuals.	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Table	   2.	   Overview	   of	   differences	   between	   mouse	   “memory”	   NK	   cells	   and	   human	  
“adaptive”	  NK	  cells	  (modified	  from	  (111)).	  
Cell	  properties	   Mouse	  memory	  NK	  cells	   Human	  adaptive	  NK	  cells	  
Antigen-­‐specific	  memory	   MCMV	  m157,	  haptens,	  VLPs	   n.d.	  
Subset	  expanding	   Ly49H+	   NKG2C+/aKIR+/CD2++	  
Key	  transcription	  factors	   zbtb32	   ê	  PLZF	  
Altered	  intracellular	  
signaling	  /	  epigenetic	  
modifications	   n.d.	  
SYK,	  FcεRγ,	  DAB2,	  	  
EAT-­‐2,	  IFNγ	  
Longevity	   yes	   yes	  
More	  potent	  upon	  re-­‐
challenge	   yes	   limited	  evidence	  
	  
	  
Mapping	  the	  human	  “KIR-­‐ome”	  to	  trace	  viral	  imprints	  in	  the	  NK	  cell	  receptor	  repertoire	  As	  discussed	  above,	   it	   is	  known	  that	  virus	   infections	  can	  cause	  changes	   in	  the	  NK	  cell	  receptor	   repertoire.	  KIR	   expression	   is	   highly	  diverse	   among	  different	   individuals	   and	  genetically	   hardwired	   in	   a	   given	  NK	   cell	   (34).	  Hence,	  we	   set	   out	   to	   examine	  whether	  changes	  in	  the	  KIR	  repertoire	  could	  be	  used	  to	  trace	  adaptation	  to	  virus	  infections	  in	  the	  NK	  cell	  compartment	  (paper	  I).	  Technological	  advancements	  in	  flow	  cytometry	  enabled	  us	   to	   investigate	   the	  human	  KIR	  profile	  by	  high-­‐resolution	  multicolor	   flow	  cytometry.	  Using	   this	  method	  we	  performed	  an	   in	  depth	  analysis	  of	   the	  human	  NK	  cell	   receptor	  repertoire	   including	   the	  major	   7	   inhibitory	   and	   activating	   KIRs,	   NKG2A,	   NKG2C	   and	  CD57.	  We	   used	   this	   combination	   of	  markers	   for	   an	   unbiased	   exploratory	   analysis	   of	  expression	  frequencies	  to	  determine	  the	  relative	  sizes	  of	  NK	  cell	  subsets	  expressing	  the	  128	  possible	  combinations	  of	  the	  7	  assessed	  KIRs.	  	  	  As	   a	   starting	  point	   in	  paper	   I,	  we	  examined	   the	  human	   “KIR-­‐ome”	   in	  more	   than	  200	  healthy	  individuals	  using	  multicolor	  flow	  cytometry	  to	  assess	  the	  surface	  expression	  of	  combinations	  of	  KIRs	  at	  the	  single	  cell	  level.	  The	  analysis	  revealed	  that	  some	  individuals	  had	  NK	  cells	  expressing	  a	  single	  KIR	  specific	  for	  HLA	  class	  I	  (self-­‐KIR)	  representing	  up	  to	  75%	  of	  the	  whole	  NK	  cell	  population.	  From	  the	  frequencies	  of	  128	  KIR	  combinations	  in	  each	  of	  the	  199	  donors	  included	  in	  the	  analysis,	  we	  used	  the	  Chauvenet’s	  criterion	  to	  define	  71	  statistical	  outliers	   (among	  a	   total	  of	  25	  472	  populations)	  with	  high	   relative	  KIR	  frequencies	  (Figure	  3).	  The	  expression	  of	  KIRs	  on	  the	  NK	  cell	  surface	  is	  stochastic	  and	  the	  co-­‐expression	  of	  different	  KIRs	  can	  be	  calculated	  according	  to	  the	  product	  rule	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using	   the	   individual	   KIR	   frequencies	   (54).	   All	   outliers	   identified	   had	   a	   significant	  deviation	   from	   the	   product	   rule	   and	   most	   had	   extreme	   phenotypic	   skewing	   of	   cells	  expressing	  both	  NKG2C	  and	  a	  single	  self-­‐KIR,	  indicating	  that	  the	  cells	  had	  undergone	  a	  clonal-­‐like	  expansion	  (Figure	  3).	  	  	  As	   previously	  mentioned,	   HCMV	   is	   known	   to	   cause	   profound	   changes	   in	   the	   NK	   cell	  compartment,	  primarily	  manifested	  through	  the	  expansion	  of	  NKG2C+	  NK	  cells	  (55).	  In	  agreement	   with	   this,	   we	   could	   only	   find	   outliers	   within	   the	   HCMV	   seropositive	  individuals.	  Reports	  of	  NK	  cell	  receptor	  repertoire	  skewing	  with	  expansion	  of	  NKG2C+	  NK	  cells	  have	  also	  been	  reported	  in	  several	  other	  viral	   infections	  such	  as	  HIV,	  chronic	  HBV/HCV,	   hanta	   virus	   and	   chikungunya	   virus	   (117-­‐120).	   However,	   the	   NK	   cell	  expansions	  observed	  in	  association	  with	  these	  viruses	  could	  only	  be	  detected	  in	  HCMV+	  patients,	   raising	   the	   question	   whether	   CMV	   is	   the	   only	   virus	   able	   to	   drive	   NK	   cell	  expansion.	   To	   address	   this	   question	   in	   our	   study,	   we	   analyzed	   the	   cohort	   for	   other	  herpes	  viruses	  including	  EBV,	  HSV-­‐1,	  HSV-­‐2	  and	  VZV.	  The	  results	  revealed	  that	  many	  of	  the	  48	  HCMV	  seronegative	  individuals	  had	  been	  exposed	  to	  these	  viruses.	  However,	  as	  none	   of	   these	   individuals	   displayed	   a	   clonal-­‐like	   expansion	   of	   adaptive	   NK	   cells,	   we	  concluded	  that	  CMV	  is	  unique	  in	  its	  ability	  to	  imprint	  the	  NK	  cell	  repertoire.	  	  	  
	  
Figure	  3.	  Outliers	  in	  the	  KIR	  receptor	  repertoires	  represent	  NK	  cells	  that	  have	  undergone	  clonal-­‐
like	   expansions.	   In	   an	   unbiased	   exploratory	   analysis	   of	   the	   relative	   sizes	   of	   128	   combinations	   of	   KIR	  expression,	  outliers	  could	  be	  identified	  by	  Chauevenet’s	  criterion	  (red	  dots).	  They	  are	  characterized	  with	  a	  skewed	  KIR	   repertoire	  where	  NK	  cells	   expressing	  a	   single	  KIR	   can	   represent	  up	   to	  75%	  of	   the	  NK	  cell	  population	  (left)	  and	  deviate	  from	  the	  product	  rule	  (right)	  indicating	  that	  they	  have	  undergone	  clonal-­‐like	  expansion.	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It	   has	   been	   shown	   that	   children	   co-­‐infected	   with	   EBV	   and	   HCMV	   have	   higher	  frequencies	   of	   NKG2C+	   NK	   cells	   compared	   to	   the	   children	   only	   infected	   with	   HCMV	  (121).	  However,	   it	   is	  unclear	  whether	  other	  viruses	   in	  HCMV	  seropositive	   individuals	  can	   drive	   the	   expansion	   of	   NK	   cells	   already	   primed	   by	   HCMV	   or	   if	   other	   acute	   viral	  infections	   cause	  a	   subclinical	   reactivation	  of	  HCMV	   that	  drives	   the	  NK	  cell	   expansion.	  Interestingly,	  in	  contrast	  to	  HCMV,	  acute	  symptomatic	  primary	  EBV	  infection	  has	  been	  associated	  with	  an	  accumulation	  of	  early-­‐differentiated	  (CD56dimNKG2A+)	  NK	  cells	  (122,	  123).	  A	  recently	  published	  longitudinal	  study	  of	  EBV	  naïve	  college	  students	  showed	  that	  neither	  acute	  EBV	  infection	  nor	  latent	  EBV	  infection	  could	  induce	  expansion	  of	  NKG2C+	  NK	   cells	   regardless	   of	   HCMV	   serostatus	   in	   the	   individuals.	   Instead,	   they	   noted	   an	  expansion	   of	   CD56dimNKG2A+CD57+	   NK	   cells	   in	   the	   HCMV	   seropositive	   individuals	  experiencing	   acute	   EBV	   infection,	  whereas	   the	   same	   population	  was	   stable	   in	   HCMV	  seronegative	  individuals	  (122).	  Another	  study	  by	  Azzi	  et	  al,	  confirms	  the	  expansion	  of	  CD56dimNKG2A+CD57+	   NK	   cells	   following	   EBV	   infection.	   However,	   in	   this	   study	   the	  CD56dimNKG2A+CD57+	   subset	  was	   elevated	   in	   both	  HCMV+	   and	  HCMV-­‐	   individuals.	   In	  addition	   to	   this,	   they	   showed	   that	   this	   subset	   of	   early-­‐differentiated	   NK	   cells	  preferentially	   target	   lytic	   EBV-­‐infected	   B	   cells	   in	   vitro	   (123).	   Despite	   differences	  whether	   CD56dimNKG2A+CD57+	   NK	   cells	   expand	   in	   HCMV-­‐	   individuals	   following	   EBV	  infection,	   both	   studies	   conclude	   that	   instead	   of	   NKG2C+	   NK	   cell	   expansion	   an	  accumulation	  of	  CD56dimNKG2A+CD57+	  NK	  cells	  will	  occur,	  suggesting	  that	  EBV	  does	  not	  drive	  adaptive	  NK	  cell	  expansion.	  	  Furthermore,	   a	   longitudinal	   study	   of	   one	   adult	   HIV	   patient	   receiving	   HAART	   had	  emergence	  of	  NKG2C+	  NK	  cell	  expansions	  after	  treatment	  when	  viral	  load	  was	  cleared.	  Interestingly,	  this	  subset	  kept	  expanding	  over	  time	  for	  at	   least	  12	  months	  without	  the	  presence	   of	   the	   virus	   (124).	   This	   case	   indicate	   that	   the	   HIV	   viral	   load	   per	   se	   is	   not	  driving	  the	  expansion,	  suggesting	  that	  other	  mechanisms	  related	  to	  HIV	  infection	  such	  as	  HCMV	  reactivation	   trigger	   the	  NK	  cells	   to	  expand.	  Hence,	   to	  date,	  no	  other	  viruses	  except	   from	  CMV	  have	  been	   shown	   to	  be	   able	   to	  drive	   the	   expansion	  of	   adaptive	  NK	  cells.	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3.2 INSIGHTS INTO ADAPTIVE NK CELL BIOLOGY 	  
Definition	  of	  Adaptive	  NK	  cells	  During	  recent	  years	  the	  term	  “adaptive”	  NK	  cells	  is	  frequently	  used	  for	  the	  specific	  NK	  cell	   expansions	   occurring	   after	   HCMV	   infection.	   However,	   a	   strict	   definition	   of	   this	  population	  is	  not	  yet	  available	  and	  intensive	  research	  resources	  are	  now	  focused	  on	  this	  newly	  identified	  NK	  cell	  population.	  Previous	  studies	  have	  associated	  this	  subset	  with	  a	  more	  mature	  phenotype	  defined	  by	   several	  differentiation	  markers	   (108).	   In	  paper	   I	  we	   examined	   the	   phenotypic	   properties	   of	   the	   identified	   outliers.	   In	   addition	   to	   the	  predominant	  expression	  of	  a	  self-­‐KIR,	  we	  also	  found	  that	  the	  NK	  cell	  expansions	  express	  markers	  associated	  with	  a	  more	  mature	  and	  differentiated	  phenotype	  characterized	  by	  downregulation	   of	   CD161,	  NKp30,	  NKp46,	   Siglec-­‐7,	   Siglec-­‐9	   and	   CD7	   in	   parallel	  with	  upregulation	  of	  CD57,	  CD2	  and	  LIR-­‐1.	  	  	  Furthermore,	  several	  research	  groups	  have	  observed	  an	  NK	  cell	  population	  with	  FcεRIγ	  deficiency	   in	   individuals	   previously	   being	   exposed	   to	   HCMV	   (125,	   126).	   FcεRIγ	   is	   a	  signaling	  adaptor	  associated	  with	  the	  Fc-­‐receptor	  CD16.	  The	  phenotypic	  properties	  of	  the	   FcεRIγ	   deficient	   NK	   cells	   were	   mostly	   overlapping	   with	   the	   NK	   cell	   expansions	  associated	  with	   HCMV	   infection	   as	   they	   express	   high	   levels	   of	   NKG2C	   and	   self-­‐KIRs,	  suggesting	  it	  being	  another	  marker	  for	  adaptive	  NK	  cells.	  Following	  the	  discovery	  that	  a	  signaling	   molecule	   could	   define	   adaptive	   NK	   cells,	   global	   epigenetic	   profiling	   have	  extended	  the	  list	  of	  molecular	  imprints	  within	  the	  adaptive	  NK	  cell	  compartment.	  	  	  In	   2015,	   the	   research	   groups	   of	   Yenan	   Bryceson	   and	   Sungjin	   Kim	   found	   evidence	   of	  DNA	  methylation-­‐dependent	  allelic	  silencing	  of	  several	  NK	  cell	  signaling	  proteins	  such	  as	   SYK,	   EAT-­‐2	   and	   DAB2	   as	  well	   as	   deficiency	   of	   the	   transcription	   factors	   PLZF	   and	  IKZF2	  in	  the	  adaptive	  NK	  cells	  (127,	  128).	  PLZF	  is	  known	  to	  interact	  with	  the	  promoter	  regions	  of	  SYK,	  EAT-­‐2	  and	  FcεRIγ,	  hence	  the	  downregulation	  of	  PLZF	  might	  contribute	  to	   changes	   in	   these	  molecules.	   Furthermore,	   cultures	   of	   NK	   cell	   clones	   revealed	   that	  SYK-­‐deficient	   NK	   cells	   maintained	   their	   SYK	   expression	   and	   functional	   attributes	  despite	   several	   cell	   divisions,	   suggesting	   that	   the	   molecular	   modifications	   and	  functional	   characteristics	   are	   inherited	   by	   daughter	   cells,	   another	   adaptive	   NK	   cell	  feature	  paralleling	  with	  T	  cell	  memory	  (128).	  Together,	   these	  studies	  demonstrated	  a	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series	  of	  unique	  epigenetic	  fingerprints	  in	  adaptive	  NK	  cells	  with	  important	  implications	  for	  their	  functionality.	  	  	  In	   paper	   I	   we	   tested	   the	   functionality	   of	   the	   adaptive	   NK	   cells	   compared	   to	  conventional	   NK	   cells.	   Generally,	   when	   NK	   cells	   mature	   and	   become	   more	  differentiated,	  they	  become	  more	  cytotoxic	  and	  less	  responsive	  to	  cytokine	  stimulation	  (92).	   As	   the	   adaptive	   NK	   cells	   are	   characterized	   by	   a	   mature	   and	   differentiated	  phenotype	   we	   tested	   their	   response	   to	   innate	   cytokines	   as	   well	   as	   their	   capacity	   to	  mediate	  ADCC.	  In	  line	  with	  the	  differentiated	  phenotype,	  the	  adaptive	  NK	  cells	  displayed	  high	   IFN-­‐γ	   production	   when	   stimulated	   with	   RAJI	   cells	   coated	   with	   rituximab	   (anti-­‐CD20	   mAb),	   and	   less	   IFN-­‐γ	   response	   to	   IL-­‐12+IL-­‐18	   stimulation	   when	   compared	   to	  conventional	   NK	   cells.	   The	   heightened	   IFN-­‐γ	   response	   in	   relation	   to	   ADCC	   could	   be	  explained	  by	  a	  study	  by	  Luetke-­‐Eversloh	  et	  al.,	  who	  discovered	  that	  mature	  NK	  cells	  are	  demethylated	   at	   the	   conserved	   non-­‐coding	   sequence	   (CNS1)	   of	   the	   IFN-­‐γ	   promoter	  (129).	  Further	  demonstrating	  the	  importance	  of	  CD16	  engagement	  in	  adaptive	  NK	  cells,	  FcεRIγ-­‐deficient	  NK	  cells	  were	  found	  to	  respond	  strongly	  to	  infected	  target	  cells	  in	  the	  presence	   of	   virus-­‐specific	  mAbs,	  while	   the	   same	  NK	   cells	   displayed	  poor	   response	   to	  direct	  stimulation	  of	  infected	  target	  cells	  (128).	  	  	  Although	  many	  markers	  have	  been	  identified	  for	  adaptive	  NK	  cells,	  they	  are	  not	  always	  expressed/downregulated	   simultaneously	  on	   the	  NK	   cells	   expanding	   following	  HCMV	  infection	  and	  a	  uniform	  definition	  of	  the	  adaptive	  NK	  cells	  does	  not	  exist.	  However,	  the	  common	  denominator	  for	  the	  adaptive	  NK	  cells	  is	  that	  they	  represent	  mature	  NK	  cells	  at	  the	   very	   end	   of	   the	   differentiation	   process,	   both	   with	   regards	   to	   phenotype	   and	  function.	  	  	  
Emergence	  and	  maintenance	  of	  adaptive	  NK	  cells	  In	  mice,	  a	  long-­‐lived	  “memory”	  NK	  cell	  pool	  is	  formed	  after	  MCMV	  infection	  is	  resolved	  (113).	   Similarly,	   during	   acute	   HCMV	   infection	   occurring	   following	   stem	   cell	  transplantation,	   a	   dynamic	   pattern	   characterized	   by	   expansion/contraction	   of	   the	  adaptive	  NK	  cell	  subset	  could	  be	  observed	  (116,	  130).	  In	  contrast	  to	  these	  findings,	  we	  found	  that	  the	  NK	  cell	  expansions	  associated	  with	  HCMV	  are	  stable	  over	  time	  in	  healthy	  individuals.	   In	  paper	  I	  we	  monitored	  healthy	  adults	   longitudinally	   for	  KIR	  expression	  patterns,	  ranging	  from	  6	  months	  to	  4	  years.	  These	  analyses	  revealed	  that	  the	  subset	  of	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expanded	   NK	   cells	   remained	   stable	   in	   both	   composition	   and	   size	   at	   all	   time	   points	  analyzed.	  However,	  a	  more	  dynamic	  pattern	  could	  be	  observed	  when	  analyzing	  a	  small	  cohort	  of	  children	  sampled	  at	  3	  different	   time	  points	  (at	  birth,	  2	  years	  and	  5	  years	  of	  age).	  Adaptive	  NK	  cell	  populations	  in	  HCMV	  infected	  2-­‐year-­‐old	  children	  declined	  in	  size	  over	  the	  course	  of	  three	  years.	  This	  indicates	  that	  although	  the	  changes	  in	  the	  NK	  cell	  compartment	  were	  stable	  over	   time	   in	  healthy	  adults,	   they	  can	  be	  more	  dynamic	  and	  might	  even	  disappear	  at	  a	  later	  stage,	  at	  least	  during	  acute	  infection	  and	  in	  children.	  	  	  The	  extremely	  stable	  composition	  of	   the	  adaptive	  NK	  cell	   compartment	  during	  HCMV	  latency	   begs	   the	   question	  whether	   the	   NK	   cell	   population	   formed	   post-­‐infection	   is	   a	  long-­‐lived	  memory	  pool	  or	  if	  there	  is	  a	  continuous	  replenishment	  of	  adaptive	  NK	  cells.	  In	  paper	  I	  we	  used	  721.221.AEH	  (a	  cell	  line	  deficient	  of	  MHC	  class	  I,	  but	  expressing	  high	  levels	   of	  HLA-­‐E)	   to	   stimulate	  NKG2C+	  NK	   cell	   expansions.	   From	   these	   data	  we	   learnt	  that	  the	  in	  vitro	  expanded	  subset	  emerged	  from	  CD57-­‐	  NK	  cells,	  suggesting	  a	  continuous	  replenishment	  of	  adaptive	  NK	  cells	  from	  the	  more	  immature	  NK	  cell	  pool	  (Figure	  4).	  It	  has	  to	  be	  emphasized	  that	  even	  though	  we	  show	  that	  adaptive	  NK	  cells	  can	  be	  expanded	  
in	  vitro	  when	  stimulated	  with	  target	  cells	  expressing	  HLA-­‐E,	  it	  still	  remains	  a	  question	  whether	  this	  is	  applicable	  in	  vivo	  and	  does	  not	  fully	  answer	  the	  question	  if	  adaptive	  NK	  cells	  are	  long-­‐lived	  or	  if	  continuous	  replenishment	  takes	  place.	  	  	  
	  
	  
	  
Figure	  4.	  Adaptive	  NK	  cells	  can	  be	  generated	  from	  CD57-­‐	  NK	  cells	  in	  vitro.	  NK	  cells	  expressing	  a	  self-­‐KIR	  expand	  from	  CD57-­‐	  NK	  cells	  when	  cultured	  together	  with	  221.AEH	  and	  IL-­‐15.	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Assuming	   that	   there	   is	   a	   continuous	   replenishment	   of	   adaptive	   NK	   cells,	   the	   next	  question	   that	   follows	  would	  be	  where	   the	   stimulation	  of	   adaptive	  NK	   cells	   occurs.	   In	  mice,	  Ly49H+	  NK	  cells	  have	  been	  shown	  to	  expand	  100-­‐fold	  in	  the	  spleen	  and	  1000-­‐fold	  in	   the	   liver,	   suggesting	   that	   the	  expansion	  of	  NK	  cells	  might	  be	  able	   to	  occur	   in	   these	  organs	  in	  the	  mouse	  model	  (113).	  In	  addition	  to	  this,	  a	  population	  of	  memory-­‐like	  liver-­‐resident	  NK	  cells	  with	  CD49a+DX5-­‐	  phenotype	  has	  been	  found	  in	  mice	  (131).	  Similar	  to	  the	   findings	   in	   mice,	   CD49a+DX5-­‐	   NK	   cells	   with	   adaptive	   features	   have	   also	   been	  detected	  in	  human	  livers.	  Akin	  to	  the	  adaptive	  NK	  cells	  present	  in	  peripheral	  blood,	  they	  express	  a	  narrow	  KIR	  profile	  as	  well	  as	  NKG2C,	  but	  differ	  in	  many	  other	  characteristics	  (132).	  However,	  the	  presence	  of	  liver-­‐resident	  adaptive	  NK	  cell	  subset	  did	  not	  correlate	  100%	   with	   NK	   cell	   expansions	   in	   peripheral	   blood.	   Similar	   observations	   have	   been	  noted	  in	  lung	  tissue,	  where	  high	  frequencies	  of	  adaptive-­‐like	  NK	  cells	  in	  the	  lung	  were	  not	   always	   paralleled	   by	   a	   similar	   expansion	   in	   peripheral	   blood	   (Marquardt	   and	  Michaëlsson	   unpublished	   observations).	   This	   suggests	   that	   adaptive	   NK	   cells	   may	  sometimes	   develop	   locally	   in	   response	   to	   local	   stimuli.	   Whether	   these	   responses	  depends	   on	   recruitment	   of	   precursors	   from	   peripheral	   blood	   that	   expand	   and	  differentiate	  locally	  remains	  to	  be	  determined.	  	  	  It	   is	   not	   known	  why	  HCMV	  and	  not	   other	   viruses	   can	   cause	   specific	   and	   long	   lasting	  imprints	   in	   the	  NK	  cell	  compartment.	  One	   important	   feature	  of	  HCMV	  is	   the	  ability	   to	  persist	   latently	   in	   the	  host	  with	  potential	   to	   trigger	   the	   immune	  system	  continuously.	  Another	  potentially	  important	  property	  separating	  HCMV	  from	  other	  herpes	  viruses	  is	  the	  identity	  of	  the	  cellular	  reservoir.	  HCMV	  has	  been	  shown	  to	  persist	  in	  myeloid	  cells	  during	  latency.	  It	  has	  been	  shown	  that	  monocyte	  differentiation	  plays	  an	  important	  role	  for	   HCMV	   susceptibility	   and	   reactivation	   of	   the	   virus	   (133).	   A	   study	   by	   Soderberg-­‐Naucler	  et	  al.,	  show	  production	  of	  infectious	  HCMV	  virus	  by	  latently	  infected	  monocytes	  when	   stimulated	   with	   allogeneic	   T	   cells.	   Further	   analysis	   of	   the	   myeloid	   cells	   that	  reactivated	  the	  infectious	  virus	  revealed	  that	  they	  all	  carried	  dendritic	  cell	  (DC)	  markers	  (134).	  NK	  cell	  cross	  talk	  with	  myeloid	  cells	  such	  as	  DCs,	  monocytes	  and	  macrophages	  have	  been	  found	  to	  be	  crucial	  for	  NK	  cell	  development,	  proliferation	  and	  maturation	  as	  they	   represent	   an	   important	   source	   of	   membrane	   bound	   IL-­‐15	   (135).	   Furthermore,	  studies	   in	   mice	   have	   shown	   that	   depletion	   of	   CD8α+	   cells	   in	   mice	   following	   MCMV	  infection	  inhibits	  the	  proliferation	  of	  Ly49H+	  NK	  cells	  (136).	  To	  exclude	  the	  involvement	  of	  CD8α+	  T	  cells,	  Ly49H+	  NK	  cell	  expansions	  were	  monitored	   in	   the	  presence	  of	  Thy1	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mAb	  and	  in	  B6-­‐β2M-­‐/-­‐	  mice	  (lacking	  CD8	  T	  cells).	   In	  both	  settings	  the	  Ly49H+	  NK	  cells	  proliferated	  in	  the	  same	  extent	  as	  the	  controls,	  suggesting	  a	  crucial	  role	  for	  CD8α+	  DCs	  in	  Ly49H+	  NK	  cell	  proliferation	  in	  response	  to	  MCMV	  infection.	  It	  is	  therefore	  tempting	  to	   speculate	   that	   HCMV	   infection	   can	   induce	   changes	   in	   the	   carrier	   cells	   and	   the	  interaction	   between	   NK	   cells	   and	   myeloid	   cells	   can	   both	   trigger	   and	   maintain	   the	  adaptive	  NK	  cells.	  	  
The	  role	  of	  adaptive	  NK	  cells	  in	  HCMV	  and	  HSCT	  Although	  adaptive	  NK	  cells	  seem	  to	  be	  exclusively	  associated	  with	  HCMV	  infection,	  we	  still	   have	   limited	   knowledge	   whether	   adaptive	   NK	   cells	   can	   directly	   control	   the	  infection.	   In	   2008,	   Kujipers	   and	   colleagues	   reported	   a	   case	   of	   a	   three-­‐month	   old	   girl	  with	  T-­‐B+NK+	  SCID	  phenotype	  who	  presented	  with	  a	  HCMV-­‐induced	  gastroenteritis.	  The	  infection	   resolved	   spontaneously	  without	   antiviral	   treatment	   and	   represents	   the	   first	  evidence	   of	   NK	   cells	   controlling	   HCMV	   infection	   in	   the	   absence	   of	   T	   cells.	   Further	  characterization	   of	   the	   immune	   response	   in	   the	   patient	   revealed	   an	   expansion	   of	  NKG2C+	   NK	   cells	   with	   a	   skewed	   KIR-­‐repertoire.	   As	   the	   viral	   load	   declined,	   the	  phenotype	  of	  the	  NK	  cells	  also	  normalized	  (137).	  This	  case	  indicates	  that	  the	  adaptive	  NK	   cells	   potentially	   play	   an	   important	   role	   in	   clearing	   acute	  HCMV	   infection	   and	  not	  only	  act	  as	  by-­‐standers	  in	  reaction	  to	  HCMV	  infection.	  	  In	  the	  immunosuppressed	  HSCT	  patients,	  the	  opportunistic	  HCMV	  infection	  is	  a	  major	  cause	  of	  morbidity	  and	  mortality.	  However,	  in	  the	  sense	  of	  graft	  versus	  leukemia	  (GVL)	  effects,	   a	   recent	   study	   have	   shown	   that	   HCMV	   reactivation	   and	   the	   expansion	   of	  adaptive	  NK	  cells	   following	   reactivation	   is	   associated	  with	   lower	   relapse	   rate	   in	  AML	  patients	   after	   cord-­‐blood	   allogeneic	   SCT	   (138).	   This	   suggests	   that	   spontaneously	  occurring	  adaptive	  NK	  cells	  may	  have	  beneficial	  effects	  by	  eradicating	  residual	  leukemic	  blasts	   and	   could	   be	   potentially	   desirable	   candidates	   in	   terms	   of	   NK-­‐cell	   mediated	  therapy	  targeting	  leukemia,	  which	  will	  be	  discussed	  later	  on	  in	  this	  thesis.	  	  	  
The	  mysterious	  presence/absence	  of	  adaptive	  NK	  cells	  in	  HCMV	  seropositive	  individuals	  In	   humans,	   35-­‐40%	   of	   all	   HCMV	   seropositive	   individuals	   have	   an	   expansion	   of	   the	  adaptive	  NK	  cell	  subset.	  It	  remains	  a	  mystery	  why	  not	  all	  HCMV	  seropositive	  individuals	  have	  a	  notable	  subset	  of	  adaptive	  NK	  cells.	  Potentially	   important	   for	   the	   formation	  of	  adaptive	  NK	  cells	   is	   the	  time	  point	  of	   infection	  during	   life.	   It	  has	  been	  speculated	  that	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young	   infants	   infected	   with	   HCMV	   might	   not	   be	   able	   to	   trigger	   the	   same	   immune	  response	   as	   the	   adults	   and	   therefore	   not	   expand	   the	   adaptive	   NK	   cell	   subset	   (139).	  Another	  theory	  is	  that	  akin	  to	  memory	  T	  cells	  and	  adaptive	  NK	  cells	  in	  mice,	  there	  is	  an	  expansion	  of	  an	  adaptive	  subset	  in	  direct	  response	  to	  the	  acute	  infection	  and	  once	  the	  virus	   is	   contained,	   the	   expanded	   population	   contracts	   and	   might	   even	   disappear	   in	  some	  individuals.	  In	  line	  with	  this	  hypothesis	  is	  the	  observation	  of	  the	  dynamic	  kinetics	  of	  adaptive	  NK	  cells	  in	  children	  2-­‐5	  years	  old	  in	  paper	  I,	  where	  the	  size	  of	  the	  adaptive	  NK	  cell	   compartment	  was	  decreased	  over	   time.	  Furthermore,	   some	   individuals	  might	  have	  HCMV	  reactivation	  beneath	  detectable	  levels	  in	  serum	  that	  is	  enough	  to	  trigger	  the	  NK	  cells	   to	  maintain	   the	  expanded	   subset,	   leaving	  a	   stable	   imprint	  of	   a	  population	  of	  expanded	   NK	   cells.	   Although	   HCMV	   infected	   fibroblast	   can	   trigger	   the	   expansion	   of	  NKG2C+	  NK	  cells	  in	  vitro	  (56),	  the	  infection	  alone	  in	  vivo	  might	  not	  be	  enough	  to	  trigger	  the	   expansion	   of	   adaptive	   NK	   cells	   and	   several	   accumulating	   events	   priming	   the	  immune	  system	  might	  be	  necessary	  in	  order	  to	  expand	  and	  maintain	  the	  adaptive	  NK	  cells.	   A	   recent	   study	   demonstrates	   that	   adaptive	   NK	   cells	   from	   HCMV	   seropositive	  donors	   can	   expand	  when	   stimulated	  with	   influenza	   antibodies	   (128),	   indicating	   that	  immune	  activation	  via	  other	  infections	  might	  be	  of	  importance	  in	  formation	  of	  adaptive	  NK	   cell	   responses.	   In	   a	   cohort	   of	   50	   untreated	   chronic	  HIV	   patients	   co-­‐infected	  with	  HCMV,	   the	   frequency	   of	   donors	   with	   more	   than	   10%	   adaptive	   FcεR1γ-­‐	   NK	   cells	   in	  peripheral	   blood	   reached	   approximately	   70%	   (Michaëlsson	   et	   al,	   unpublished	  observations),	   a	   frequency	  much	  higher	   than	  healthy	   controls.	  This	  partially	   suggests	  that	  the	  high	  immune	  activation	  during	  HIV	  infection	  helps	  triggering	  and	  maintaining	  the	  adaptive	  NK	  cell	  subset.	  	  	  
3.3 EDUCATION EFFECT ON ADAPTIVE NK CELLS 	  
KIR	  gene	  copy	  number	  influence	  on	  education	  and	  adaptive	  NK	  cells	  NK	  cell	   function	   is	   tuned	  via	  KIRs	   interacting	  with	  HLA	  class	   I	  molecules.	   It	  has	  been	  suggested	  that	  KIR	  gene	  copy	  number	  variation	  (CNV)	  influences	  antiviral	  immunity	  as	  multiple	   copies	   of	   an	   inhibitory	   KIR	   could	   potentially	   lead	   to	   enhanced	   NK	   cell	  education	  and	  hence	  better	  antiviral	  immunity	  (140,	  141).	  This	  could	  potentially	  affect	  the	  generation	  of	  adaptive	  NK	  cells	  in	  response	  to	  HCMV.	  In	  paper	  II	  we	  examined	  the	  effect	   of	   KIR	   CNV	   on	   the	   expression	   of	   7	   major	   inhibitory	   and	   activating	   KIRs.	   By	  combining	   a	   high	   throughput	   methodology	   for	   KIR	   gene	   typing	   and	   high-­‐resolution	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phenotypic	  analysis	  of	  KIR	  repertoires	  we	  observed,	  in	  agreement	  with	  other	  studies,	  a	  linear	  relationship	  between	  KIR	  gene	  copy	  number	  and	  the	  expression	  of	  all	  KIRs	  tested	  (44,	  140,	  142).	  	  	  
	  
Figure	  5.	  NK	  cell	  expansions	  occur	  independently	  of	  KIR	  gene	  copy	  number	  variation.	  KIR	  CNV	  was	  assessed	  in	  the	  same	  cohort	  as	  previously	  described	  in	  paper	  I.	  When	  stratifying	  the	  cohort	  according	  to	  KIR	   gene	   copy	   number,	   the	   outliers	   (red	   dots)	   were	   found	   independently	   of	   number	   of	   gene	   copies	  expressed.	  	  	  	  One	  of	  the	  features	  of	  adaptive	  NK	  cells	  that	  we	  noted	  in	  paper	  I	  was	  their	  preferential	  expression	  of	  inhibitory	  KIRs	  specific	  for	  self-­‐MHC	  class	  I	  molecules.	  Therefore,	  we	  set	  out	   to	   analyze	  whether	   KIR	   gene	   copy	   number	   had	   an	   influence	   on	   the	   skewed	   KIR	  repertoire	   observed	   among	   the	   outliers	   (described	   in	  paper	   I).	  When	   stratifying	   our	  cohort	  of	  204	  healthy	  individuals	  according	  to	  KIR	  gene	  copy	  number,	  we	  found	  that	  the	  outliers	   existed	   independently	   of	   KIR	   CNV	   (Figure	   5),	   suggesting	   that	   the	   NK	   cell	  expansions	  possessing	  an	  extreme	  KIR	  profile	  were	  not	  dependent	  on	  CNV.	  	  	  As	   education	   is	   dependent	   on	   KIR	   interactions	   with	   its	   cognate	   HLA	   ligand,	   we	  speculated	   that	   KIR	   CNV	   could	   influence	   NK	   cell	   function.	   Since	   it	   is	   impossible	   to	  discriminate	   cells	   that	   express	   1	   or	   more	   copies	   of	   the	   same	   allele,	   we	   used	   a	  combination	  of	  the	  mAbs	  GL183	  and	  EB6	  by	  taking	  advantage	  of	  their	  cross-­‐reactivity	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with	  the	  2DL3*005	  allele	  and	  investigated	  CNV	  influence	  on	  education	  at	  the	  single	  cell	  level.	  This	  made	  it	  possible	  to	  distinguish	  between	  2DL3*005	  single	  positive,	  2DL3*xxx	  single	  positive	  and	  2DL3*005/2DL3*xxx	  double	  positive	  NK	  cells	  in	  individuals	  lacking	  2DS1	  and	  2DL2/S2	  (Figure	  6).	  When	  testing	  2DL3+	  cells	  derived	  from	  HLA-­‐C1	  donors	  against	  K562	  cells,	  we	  did	  not	  observe	  any	  differences	  with	  regards	  to	  CD107a,	  IFN-­‐γ	  or	  TNF	   response	   between	   donors	   expressing	   one	   or	   two	   alleles	   of	   2DL3.	   This	  demonstrated	   that	   although	   KIR	   expression	   density	   is	   higher	   on	   NK	   cells	   expressing	  several	  KIR	  alleles,	  it	  does	  not	  influence	  education.	  	  However,	  although	  KIR	  CNV	  did	  not	  have	  any	  effect	  on	  education	  at	  the	  single	  cell	  level,	  we	  noted	  that	  in	  the	  overall	  NK	  cell	  repertoire	  more	  cells	  expressing	  the	  self-­‐KIR	  contributed	  to	  CD107a	  response.	  	  	  
	  
Figure	  6.	  Gating	  strategy	  to	  identify	  single	  and	  bi-­‐allelic	  2DL3	  expression	  in	  2DL2/S1/S2-­‐negative	  
donors.	  
	  
What	  is	  the	  role	  of	  education	  in	  adaptive	  NK	  cells?	  In	   paper	   I	   we	   show	   that	   NKG2C+	   expansions	   predominantly	   express	   a	   self-­‐specific	  inhibitory	  KIR.	  However,	  our	  study	  performed	  on	  transporter	  associated	  with	  antigen	  presentation	  (TAP)	  deficient	  individuals,	  with	  less	  than	  10%	  cell	  surface	  expression	  of	  MHC	  class	   I,	   revealed	   that	  NKG2C+	  expansions	   still	   can	  occur	  despite	   the	   lack	  of	  KIR-­‐HLA	  class	  I	  interactions	  (143).	  Interestingly,	  these	  expansions	  displayed	  polyclonal	  KIR	  profiles	  and	  despite	  poor	  responses	  to	  MHC	  deficient	  targets,	  they	  were	  able	  to	  mediate	  ADCC	  and	  respond	  to	  direct	  ligation	  of	  the	  NKG2C	  receptor.	  These	  results	  indicate	  that	  although	   HLA	   class	   I	   seem	   to	   shape	   the	   KIR	   repertoire	   during	   NK	   cell	   expansion	   in	  healthy	  individuals,	  it	  is	  not	  crucial	  for	  NKG2C+	  expansions	  to	  occur.	  Although	  education	  is	   not	   driving	   the	   expansions,	   the	   preferential	   expression	   of	   a	   self-­‐KIR	   among	   the	  adaptive	   NK	   cells	   indicate	   educated	   cells	   might	   have	   a	   proliferative	   advantage.	   In	  support	  of	  this,	  Felices	  et	  al,	  found	  that	  NK	  cells	  with	  self-­‐KIRs	  were	  less	  susceptible	  to	  apoptosis	   when	   compared	   to	   uneducated	   NK	   cells.	   Upon	   IL-­‐15	   withdrawal,	   the	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uneducated	   NK	   cells	   upregulated	   death	   receptors	   such	   as	   Fas	   and	   Bim,	   giving	   the	  educated	  NK	  cells	  survival	  advantage	  (144).	  In	  addition	  to	  the	  survival	  advantage,	  one	  could	  also	  assume	  that	  educated	  cells	  could	  reach	  higher	  activity	  levels	  when	  stimulated	  through	   HLA-­‐E-­‐NKG2C	   interactions,	   as	   the	   requirements	   for	   full	   activation	   of	   the	  educated	  NK	  cells	   are	   fulfilled	  when	  HCMV	  downregulates	  MHC	  class	   I.	  However,	   the	  quality	   of	   education	   does	   not	   seem	   to	   play	   an	   important	   role	   in	   shaping	   the	   KIR	  repertoire.	   It	   is	   known	   that	   HLA-­‐C2	   binds	   to	   2DL1	  with	   higher	   affinity	   than	   HLA-­‐C1	  binds	  to	  2DL3	  (145)	  and	  in	  paper	  I	  the	  analysis	  of	  the	  NK	  cell	  repertoire	  did	  not	  reveal	  any	  obvious	  deviation	   towards	  2DL1	  expression	  among	   the	  expansions	   in	   individuals	  being	  HLA-­‐C1/C2.	  	  	  	  
3.4 POTENTIAL DRIVERS OF ADAPTIVE NK CELLS 	  
Adaptive	  NK	  cells	  in	  the	  absence	  of	  NKG2C	  	  Despite	   evidence	   indicating	   that	   NKG2C	   plays	   a	   central	   role	   in	   the	   NK	   cell	   response	  against	  HCMV,	  it’s	  not	  essential	  for	  survival	  and	  reproduction.	  Approximately	  4%	  of	  the	  human	  population	  has	  a	  complete	  deletion	  of	   the	  KLRC2/NKG2C	  gene	  (NKG2C-­‐/-­‐)	   (57-­‐59).	   Although	   NKG2C	   deletion	   in	   patients	   with	   HIV	   infection	   is	   associated	   with	   an	  increased	  risk	  of	  fast	  disease	  progression,	  HCMV	  seropositive	  NKG2C-­‐/-­‐	  adults	  remains	  healthy	  and	  seem	  to	  be	  able	  to	  fully	  control	  the	  HCMV	  infection.	  This	  raises	  the	  question	  whether	  adaptive	  NK	  cell	  responses	  are	  physiological	  relevant	  or	  if	  the	  loss	  of	  NKG2C-­‐driven	   adaptive	   NK	   cell	   responses	   are	   compensated	   for	   by	   other	   immune	   cells	   or	  redundant	  adaptive	  NK	  cell	  subsets.	  In	  paper	  I	  we	  show	  that	  although	  the	  majority	  of	  the	  adaptive	  NK	  cells	  were	  found	  within	  the	  NKG2C+NKG2A-­‐	  subset,	  some	  were	  NKG2C-­‐negative.	  When	   further	   analyzing	   these	   subsets,	  we	   observed	   that	   instead	   of	   NKG2C,	  these	  expansions	  expressed	  an	  activating	  KIR	  (2DS2,	  2DS4).	  These	  results	  suggest	  a	  role	  for	   activating	  KIRs	  as	   a	  driver	  of	   adaptive	  NK	  cells	   in	   the	  absence	  of	  NKG2C.	  Further	  supporting	   our	   data,	   Della	   Chiesa	   et	   al.,	   published	   a	   study	   of	   patients	   carrying	   a	  homozygous	   deletion	   of	   the	   NKG2C	   gene	   undergoing	   umbilical	   cord	   blood	  transplantation	  (UCBT)	  (146).	  The	  results	  from	  this	  study	  revealed	  that	  despite	  the	  lack	  of	  NKG2C,	  these	  patients	  were	  able	  to	  mount	  activating	  KIR+	  adaptive	  NK	  cell	  responses	  to	  HCMV	  infection.	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To	  further	  examine	  adaptive	  NK	  cell	  responses	  in	  the	  absence	  of	  NKG2C	  we	  established	  a	  bio	  bank	  of	  healthy	  individuals	  lacking	  the	  NKG2C	  gene	  (paper	  III).	  By	  screening	  2208	  healthy	   blood	   donors	   for	   surface	   and	   gene	   expression	   of	   NKG2C,	   we	   found	   80	  individuals	   with	   a	   complete	   deletion	   the	   NKG2C	   gene.	   As	   all	   these	   individuals	   are	  healthy,	  we	  hypothesized	  that	  other	  cellular	  mechanisms	  must	  compensate	  for	  the	  loss	  of	  NKG2C.	  As	  T	  cells	  are	  considered	   the	  most	   important	  players	   in	  HCMV	  control,	  we	  investigated	   whether	   NKG2C	   deletion	   had	   any	   impact	   on	   T	   cell	   immunity	   in	   HCMV	  infection.	  To	  our	  surprise,	  no	  difference	  in	  frequency	  of	  HCMV	  specific	  T	  cells	  was	  seen	  between	  NKG2C+	  and	  NKG2C-­‐/-­‐	  donors,	  indicating	  that	  the	  lack	  of	  NKG2C	  had	  no	  major	  impact	   on	   the	   T	   cell	   response	   to	   HCMV.	   Interestingly,	   we	   found	   an	   accumulation	   of	  terminally	   differentiated	   effector	   memory	   CD45RA+	   CD8	   T	   cells	   in	   younger	   HCMV	  seropositive	  NKG2C-­‐/-­‐	  individuals,	  suggesting	  a	  stronger	  CD8	  T	  cell	  response	  in	  the	  early	  phase	  of	  HCMV	   infection	   in	   the	   absence	  of	  NKG2C-­‐driven	  adaptive	  NK	  cell	   immunity.	  Further	   supporting	   the	   importance	   of	   T	   cells	   in	   HCMV	   infection	   among	   NKG2C-­‐/-­‐	  individuals	   in	  early	   life	   is	   the	  results	   from	  a	  study	  published	  by	  Goodier	  et	  al,.	   In	   this	  relatively	  large	  cohort	  of	  children	  and	  adults	  from	  rural	  Gambia,	  the	  influence	  of	  NKG2C	  gene	  copy	  number	  on	  HCMV	  infection	  was	  investigated	  by	  measuring	  HCMV	  antibody	  titers.	  Among	  the	  individuals	  analyzed	  they	  observed	  that	  NKG2C-­‐/-­‐	  children	  (under	  the	  age	  of	  10)	  had	  higher	  antibody	  titers	  as	  compared	  to	  NKG2C+/-­‐	  and	  NKG2C+/+	  children.	  This	  effect	  was	  diminished	  in	  individuals	  older	  than	  10,	  suggesting	  a	  less	  efficient	  HCMV	  control	  by	  NKG2C-­‐/-­‐	  individuals	  in	  early	  life	  that	  can	  be	  compensated	  for	  at	  a	  later	  stage	  (147).	  	  	  As	  no	  major	  impact	  on	  T	  cell	  immunity	  against	  HCMV	  was	  noted,	  we	  hypothesized	  that	  there	  must	  be	  a	  redundancy	  in	  the	  adaptive	  NK	  cell	  responses	  to	  HCMV	  infection.	  In	  our	  analysis	   we	   found	   that	   NKG2C-­‐/-­‐	   individuals	   were	   able	   to	   mount	   adaptive	   NK	   cell	  responses	   following	   HCMV	   infection	   and	   the	   frequency	   of	   individuals	   having	   NK	   cell	  expansions	  was	  similar	  to	  the	  cohort	  of	  NKG2C+	  individuals.	  Based	  on	  our	  previous	  data	  suggesting	  that	  activating	  KIRs	  may	  drive	  the	  adaptive	  NK	  cell	  responses	  we	  set	  out	  to	  investigate	  whether	  this	  was	  the	  case	  also	  for	  the	  adaptive	  NK	  cell	  responses	  seen	  in	  the	  NKG2C-­‐/-­‐	   cohort.	   Although	   activating	  KIRs	  were	   expressed	   in	   some	   of	   the	   expansions	  identified,	   the	  majority	   of	   the	   expansions	   in	   the	   NKG2C-­‐/-­‐	   cohort	   did	   not	   express	   an	  activating	   KIR,	   suggesting	   that	   other	   receptors	   than	   NKG2C	   and	   activating	   KIRs	   can	  drive	  the	  adaptive	  NK	  cell	  responses.	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Identification	  of	  other	  drivers	  of	  adaptive	  NK	  cell	  responses	  To	   investigate	   whether	   other	   activating	   receptors	   than	   activating	   KIRs	   could	  compensate	  for	  the	  loss	  of	  NKG2C	  in	  adaptive	  NK	  cells	  we	  phenotyped	  the	  NK	  cells	  with	  a	   broad	   panel	   of	   activating	   receptors.	   The	   characterization	   of	   the	   adaptive	   NK	   cells	  compared	  to	  conventional	  NK	  cells	  revealed	  that	  most	  activating	  receptors	  in	  adaptive	  NK	  cells	  were	  either	  downregulated	  or	  stable	   in	  expression.	  Only	   two	  receptors	  were	  upregulated,	   CD2	   and	  DNAM-­‐1	   (paper	   I	   and	   III).	   Both	   CD2	   and	  DNAM-­‐1	   have	   been	  shown	  to	  synergize	  with	  NKp46	  and	  stimulate	  resting	  NK	  cells	  (148).	  Nabekura	  et	  al.,	  have	  demonstrated	  that	  DNAM-­‐1	  co-­‐stimulation	   is	  critical	   for	   the	  expansion	  of	  MCMV	  specific	   Ly49H+	  NK	   cells	   in	  mice	   (70).	   Blockade	   of	   DNAM-­‐1	   using	   anti-­‐DNAM-­‐1	  mAb	  abrogated	   the	   expansion	   of	   MCMV-­‐specific	   Ly49H+	   NK	   cells	   and	   inhibited	   the	  generation	  of	  memory	  NK	  cells.	  Furthermore,	  Ly49H+	  NK	  cells	  from	  DNAM-­‐1	  deficient	  mice	  displayed	  defective	  expansion	  in	  effector	  NK	  cells	  and	  generation	  of	  long-­‐lived	  NK	  cells.	  They	  also	  expanded	  poorly	  when	  re-­‐challenged	  with	  MCMV	  and	  showed	  impaired	  protection	  against	  MCMV	  infection.	  	  	  CD2	  is	  a	  major	  co-­‐activating	  receptor	  on	  NK	  cells	  and	  T	  cells.	  Its	  natural	  ligand,	  CD58,	  is	  expressed	  on	  a	  variety	  of	  tissues.	  In	  addition	  to	  this,	  adaptive	  NK	  cells	  have	  been	  shown	  to	  display	  enhanced	  ADCC	  compared	  to	  conventional	  NK	  cells	  (paper	  I).	  In	  light	  of	  these	  data,	  together	  with	  recent	  evidence	  of	  antibody-­‐mediated	  recognition	  of	  HCMV-­‐infected	  cells	  driving	  the	  expansion	  of	  adaptive	  NK	  cells	  (128),	  we	  wanted	  to	  address	  whether	  other	   activating	   receptors,	   in	   particular,	   CD2	   and	   DNAM-­‐1,	   could	   co-­‐stimulate	   the	  activation	  pathways	   in	  adaptive	  NK	  cells	   in	  relation	  to	  HCMV	  infection.	  To	   investigate	  this,	  a	  broad	  panel	  of	  activating	  receptors	  was	  tested	  in	  a	  redirected	  ADCC	  assay	  using	  the	  murine	  cell	  line	  P815	  coated	  with	  different	  activating	  receptor	  antibodies	  including	  CD16,	   CD2,	  DNAM-­‐1,	  NKG2D,	   2B4,	  NKp46	   and	  NKp30,	   alone	   or	   in	   combinations.	  Our	  data	   revealed	   as	   expected,	   that	   no	   activating	   receptor	   alone	   could	   induce	   NK	   cell	  function	  except	  CD16,	  which	  was	  in	  line	  with	  previous	  work	  (148).	  When	  the	  NK	  cells	  were	   co-­‐stimulated	  with	  CD16	   together	  with	  CD2,	   the	  adaptive	  NK	  cell	   response	  was	  further	   enhanced	   whereas	   no	   other	   combinations	   of	   the	   activating	   receptors	   tested	  could	  affect	  the	  NK	  cell	  response.	  In	  contrast	  to	  the	  studies	  in	  mice	  where	  DNAM-­‐1	  plays	  a	   crucial	   role	   in	   co-­‐stimulation	   of	   memory	   NK	   cell	   formation,	   we	   did	   not	   notice	   a	  heightened	   response	   of	   adaptive	   NK	   cells	   when	   co-­‐stimulating	   CD16	   with	   DNAM-­‐1	  
(Figure	  7).	  To	  further	  investigate	  the	  role	  of	  CD2	  in	  ADCC	  we	  tested	  RAJI	  cells	  coated	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with	   rituximab	   in	   the	   presence	   or	   absence	   of	   anti-­‐CD2	   mAb.	   In	   line	   with	   previous	  results,	   the	   adaptive	   NK	   cell	   function	   displayed	   a	   significant	   drop	   when	   CD2	   was	  blocked	  on	  the	  adaptive	  NK	  cells.	  	  	   	  
Figure	   7.	   CD2	   synergize	   with	   CD16,	  
stimulating	   adaptive	   NK	   cells.	   IFN-­‐γ,	   TNF	  and	  CD107a	  were	  measured	   in	   conventional	  and	   adaptive	  NK	   cells	   after	   stimulation	  with	  P815	   cells	   coated	   with	   the	   indicated	  antibodies	  alone	  or	  in	  combinations.	  	  	  	  	  	  	  	  	  	  	  As	   a	   vast	  majority	   of	   adaptive	   NK	   cells	   is	   associated	  with	   NKG2C	  we	   set	   out	   to	   test	  whether	  CD2	  also	  could	  synergize	  with	  NKG2C.	  Using	  the	  same	  redirected	  ADCC	  assay	  as	  previously	  described,	  we	  stimulated	  the	  adaptive	  NK	  cells	  with	  the	  combinations	  of	  CD2,	  NKG2C	  and	  CD16	  mAbs.	  Interestingly,	  we	  found	  that	  CD2	  also	  could	  enhance	  NK	  cell	   function	  when	   co-­‐stimulated	  with	  NKG2C.	   The	   importance	   of	   CD2	   co-­‐stimulation	  was	  further	  revealed	  when	  NKG2C+	  NK	  cells	  stimulated	  with	  221.AEH	  cell	  line	  displayed	  a	   decrease	   in	   function	   in	   the	   presence	   of	   anti-­‐CD2	  mAb.	   Together	   these	   results	   shed	  light	  on	  the	  importance	  of	  co-­‐stimulatory	  signals	  from	  CD2	  in	  human	  adaptive	  NK	  cell	  responses.	  These	  findings	  parallel	  the	  prevailing	  model	  for	  T	  cell	  activation	  where	  three	  distinct	  signals	  are	  required	  for	  optimal	  activation	  (149).	  “Signal	  1”	  represents	  antigen	  recognition	  by	  the	  T	  cell	  receptor	  (TCR),	  “signal	  2”	  includes	  the	  second	  activating	  signal	  provided	  by	  co-­‐stimulatory	  receptor	  CD28	  binding	  and	  “signal	  3”	  involves	  the	  cytokines	  secreted	  by	  antigen	  presenting	  cells	  (APCs)	  that	  binds	  to	  cytokine	  receptors	  on	  T	  cells	  
    31 
polarizing	   them	   further	   towards	   an	   effector	   phenotype.	   Akin	   to	   memory	   NK	   cell	  formation	   in	   mouse	   models	   where	   DNAM-­‐1	   serves	   as	   the	   important	   co-­‐stimulatory	  “signal	  2”	  (70),	  we	  show	  in	  paper	  III	  that	  this	  model	  may	  be	  applicable	  also	  for	  human	  adaptive	  NK	  cells,	  where	  co-­‐stimulatory	  signals	  from	  CD2	  represents	  “signal	  2”	  (Figure	  
8).	  	  Recent	   data	   have	   shown	   that	   CD58	   is	   overexpressed	   on	   HCMV	   infected	   fibroblasts	  (150),	   potentially	   leading	   to	   an	   overstimulation	   of	   CD2	   on	   adaptive	   NK	   cells.	  Upregulation	   of	   CD58	   together	   with	   HCMV-­‐induced	   loss	   of	   HLA	   class	   I	   on	   the	   cell	  surface	  makes	  it	  is	  possible	  for	  self-­‐KIR+	  adaptive	  NK	  cells	  to	  be	  stimulated	  via	  CD2	  and	  CD16.	  In	  summary,	  our	  results	  from	  paper	  III	  reveal	  a	  redundancy	  in	  adaptive	  NK	  cell	  responses	   where	   CD2	   and	   CD16	   together	   with	   HCMV	   antigens	   might	   be	   one	   of	   the	  currently	  unknown	  drivers	  of	   the	  adaptive	  NK	  cell	   responses	  and	   that	   co-­‐stimulatory	  signals	  of	  NK	  cells	  might	  be	  of	  more	  importance	  than	  previously	  thought.	  	  	  	  
	  
Figure	  8.	  Overview	  of	  the	  potential	  drivers	  of	  adaptive	  NK	  cells.	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3.5 IMPLICATIONS OF ADAPTIVE NK CELLS IN NK CELL-BASED CANCER 
THERAPY 	  
Expansion	  of	  adaptive	  NK	  cells	  for	  cancer	  therapy	  In	  order	  for	  NK	  cells	  to	  efficiently	  kill	  tumor	  cells,	  the	  requirement	  of	  education	  needs	  to	  be	  fulfilled	  simultaneously	  as	  HLA	  class	  I	  is	  down	  regulated	  on	  the	  tumor.	  Educated	  NK	  cells	   transferred	   over	   HLA	   barriers	   are	   supposedly	   the	  most	   efficient	   killers	   and	   are	  referred	  to	  as	  alloreactive	  NK	  cells	  and	  this	  transplantation	  setting	  is	  theoretically	  the	  most	   beneficial	   one.	   Indeed,	   in	   2002	   Ruggeri	   and	   colleagues	   reported	   successful	  allogeneic	  NK	  cell	  transplantations	  (151).	  In	  a	  cohort	  of	  112	  patients	  with	  AML	  or	  ALL	  receiving	   hematopoietic	   transplants	   from	   haploidentical	   donors,	   they	   observed	   that	  leukemia	   relapse	   was	   eliminated	   in	   the	   AML	   patients	   with	   KIR-­‐HLA	   mismatch.	   The	  results	   for	   the	   ALL	   patients	  were	   not	   as	   successful	   as	   relapse	   rate	   remained	   at	   high	  frequencies	   regardless	   of	   HLA-­‐KIR	   mismatched	   transplants	   or	   not.	   Although,	   this	  pioneering	  study	  demonstrated	  extraordinary	   results	   for	  AML	  patients	   receiving	  KIR-­‐mismatched	   transplants,	   later	   studies	   has	   proven	   it	   difficult	   to	   reproduce	   such	   great	  numbers	  using	  allogeneic	  HSCT.	  Many	  groups	  during	  the	  following	  years	  have	  reported	  highly	   variable	   outcomes	   of	   patients	   receiving	   allogeneic	   HSCT	   (152).	   Hence,	   further	  studies	  were	  needed	  in	  order	  to	  improve	  the	  outcome	  for	  patients	  with	  hematological	  malignancies.	   Over	   the	   past	   years,	   the	   research	   field	   of	   NK	   cell	   mediated	  immunotherapy	   has	   stepped	   into	   the	   spotlight.	   One	   key	   challenge	   is	   to	   understand	  which	   NK	   cells	   are	   the	   optimal	   to	   transfer	   and	   being	   able	   to	   generate	   them	   in	   large	  numbers.	  Various	  protocols	  for	  NK	  cell-­‐based	  therapy	  are	  now	  being	   investigated	  and	  many	   strategies	   generating	   NK	   cells	   are	   being	   evaluated,	   including	   de	   novo	  development	   of	   NK	   cells	   from	   induced	   pluripotent	   stem	   cells	   (iPSC)	   and	   human	  embryonic	   stem	   cells	   (hESC),	   genetic	   manipulation	   with	   CARs,	   prestimulation	   of	   NK	  cells	   with	   cytokine	   cocktails	   or	   feeder	   cells	   as	   well	   as	   expansion	   of	   NK	   cells	   using	  artificial	  antigen-­‐presenting	  cells	  (aAPCs)	  (153-­‐157).	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Figure	  9.	  In	  vitro	  expansion	  of	  educated	  NK	  cells.	  NK	  cells	  co-­‐cultured	  together	  with	  221.AEH	  and	  IL-­‐15	  over	  14	  days	  show	  an	  expansion	  of	  NKG2C+	  NK	  cells	  with	  skewing	  in	  their	  KIR	  repertoire	  towards	  a	  self-­‐KIR.	  	  Many	   clinical	   trials	   involving	   GMP-­‐compliant	   NK	   cell	   expansion	   protocols	   yield	   great	  numbers	  of	  NK	  cells	  for	  immunotherapy	  and	  show	  promising	  results	  (156).	  However,	  to	  fully	   exploit	   the	   specificity	   of	   the	  missing	   self	   response	   in	   transfer	   of	  NK	   cells	   across	  HLA	   barriers,	   one	   would	   need	   to	   selectively	   expand	   specific	   subset	   of	   NK	   cells	  expressing	  one	  single	  self-­‐KIR.	  In	  paper	  I	  and	  paper	  IV	  we	  mimicked	  the	  natural	  HCMV	  infection	  to	  expand	  adaptive	  NK	  cells	  in	  vitro.	  We	  used	  target	  cells	  lacking	  MHC	  class	  I	  and	   expressing	   high	   levels	   of	   HLA-­‐E	   (221.AEH)	   together	   with	   IL-­‐15	   to	   stimulate	   the	  expansion	   of	   adaptive	   NK	   cells.	   This	   resulted	   in	   the	   expansion	   of	   a	   homogenous	  population	  of	  NK	  cells	  expressing	  one	  single	  self-­‐KIR	  together	  with	  NKG2C	  (Figure	  9).	  Given	  the	  fact	  that	  we	  had	  generated	  a	  population	  of	  educated	  NK	  cells	  that	  would	  be	  alloreactive	   when	   transferred	   over	   HLA	   barriers,	   we	   hypothesized	   that	   the	   in	   vitro	  expanded	   NK	   cells	   would	   display	   higher	   cytotoxicity	   compared	   to	   non-­‐expanded	   NK	  cells.	  To	  test	  this	  we	  used	  PHA	  blasts	  derived	  from	  HLA-­‐C1/C1	  (C1/C1)	  or	  HLA-­‐C2/C2	  (C2/C2)	  donors	  and	  tested	  NK	  cells	  expressing	  2DL1	  or	  2DL3	  either	  rested	  over	  night	  in	  medium	  or	  after	  14	  days	  of	  expansion	  together	  with	  221.AEH	  and	  IL-­‐15	  (paper	  IV).	  As	  predicted,	  the	  expanded	  NK	  cells	  showed	  greater	  cytotoxicity	  towards	  HLA	  mismatched	  PHA	   blasts	   compared	   to	   the	   unexpanded	   NK	   cells	   from	   the	   same	   donor.	   It	   has	  previously	   been	   reported	   that	   ALL	   blasts	   are	   resistant	   to	   NK	   cell	   lysis,	   including	   by	  clonal	  NK	  cells	  and	  cytokine	  activated	  NK92	  cells	  (151,	  158).	  To	  test	  the	  efficacy	  of	  the	  expanded	  NK	  cells,	  we	  used	  primary	  pediatric	  ALL	  blasts	  as	  targets	  in	  a	  4-­‐hour	  FACS-­‐based	   killing	   assay	   measuring	   caspase-­‐3	   and	   live/dead	   cell	   marker.	   Similar	   to	   the	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results	  obtained	  using	  PHA	  blasts,	  the	  expanded	  NK	  cells	  displayed	  potent	  killing	  of	  the	  ALL	  blasts	  in	  a	  KIR-­‐HLA	  mismatched	  setting	  (average	  killing	  approximately	  at	  70%)	  at	  an	  E:T	  ratio	  of	  5:1.	  This	  cytotoxic	  effect	  was	  fully	  inhibited	  when	  KIR-­‐HLA	  was	  matched,	  suggesting	   that	   the	   expanded	   NK	   cells	   were	   specifically	   recognizing	   the	   target	   cells	  through	  missing	  self	  (Figure	  10).	  	  
	  
Figure	   10.	   Primary	   ALL	   blasts	   are	   susceptible	   to	  
expanded	   NK	   cells.	   ALL	   blasts	   from	   three	   different	  subgroups	   derived	   from	   23	   pediatric	   patients	   being	  C1/C1,	  C1/C2	  and	  C2/C2	  were	   tested	   in	  a	  FACS	  based	  killing	   assay	   against	   expanded	   NK	   cells	   expressing	  2DL1.	  	  	  	  	  Interestingly,	  B-­‐ALL	  blasts	  have	  been	  shown	  to	  express	   low	   levels	  of	  HLA-­‐E	  (159).	  As	  our	  expanded	  NK	  cells	  all	   express	  NKG2C	  we	  wanted	   to	  delineate	   the	  contribution	  of	  NKG2C	  in	  NK	  cell	  killing	  of	  the	  target	  cells.	  To	  this	  end,	  we	  monitored	  NK	  cell	  function	  by	  measuring	  CD107a,	  TNF	  and	  IFN-­‐γ	  after	  the	  expanded	  NK	  cells	  were	  stimulated	  with	  ALL	  blasts	  in	  the	  presence	  of	  anti-­‐CD94	  mAb	  (blocking	  NKG2C).	  Surprisingly,	  we	  did	  not	  see	  an	   inhibitory	  effect	  of	  NK	  cell	   function	  when	  NKG2C	  was	  blocked,	  suggesting	   that	  the	   killing	   of	   ALL	   blasts	   was	   not	   mediated	   through	   NKG2C	   ligation.	   However,	   when	  stimulating	   the	   NK	   cells	   with	   221.AEH	   in	   the	   same	   functional	   assay,	   we	   saw	   the	  expected	  decrease	   in	  NK	  cell	   function	  when	  anti-­‐CD94	  blocking	  mAb	  was	  used.	  These	  results	   show	   that	   although	   NKG2C	   is	   not	   crucial	   for	   killing	   blasts	   with	   low	   HLA-­‐E	  expression,	   it	  could	  still	  be	  stimulated	  via	  target	  cells	  expressing	  high	  levels	  of	  HLA-­‐E,	  which	  has	  been	  reported	  for	  many	  tumor	  types	  (160).	  	  	  
Outlook:	  NK	  cell	  mediated	  cancer	  therapy	  As	   for	   today,	  NK	   cell	   therapy	   still	   has	  many	   obstacles	   to	   overcome.	   The	   results	   from	  
paper	  IV	  demonstrate	  the	  possibility	  to	  specifically	  expand	  NK	  cells	  expressing	  a	  single	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KIR.	  One	  obvious	  implication	  for	  the	  expanded	  adaptive	  NK	  cells	  discussed	  in	  paper	  IV	  is	   transfer	  over	  HLA	  barriers.	  However,	   the	  major	  concern	   in	   those	  settings	  would	  be	  the	  cause	  of	  graft	  versus	  host	  disease	  (GVHD)	  as	  no	  inhibitory	  signal	  for	  self-­‐tolerance	  would	  be	  present.	  Until	  recently	  no	  report	  of	  GVHD	  of	  patients	  receiving	  allogeneic	  NK	  cell	   infusions	  existed.	  However,	  a	  recently	  published	  phase	  I	  trial	  of	  patients	  receiving	  IL-­‐15/4-­‐1BBL	   activated	  NK	   cells	   encountered	  unexpectedly	   high	   frequencies	   of	   acute	  GVHD	   (161).	   It	   is	   however	   important	   to	   note	   that	   in	   this	   study,	   GVHD	   was	   more	  frequent	   in	  matched	  unrelated	  donor	   (MUD)	   transplants	   than	  matched	   sibling	   (MSD)	  transplants.	  This,	  together	  with	  the	  higher	  CD3	  chimerism	  in	  MUD	  transplants	  suggests	  that	   the	   infused	   NK	   cells	   augmented	   T-­‐cell	   alloreactivity	   causing	   GVHD.	   Potentially,	  subclinical	   inflammation	   upregulate	   stress-­‐induced	   ligands	   on	   epithelial	   cells	   and	  stimulate	  the	  IL-­‐15/4-­‐1BBL	  activated	  NK	  cells,	  which	  express	  high	   levels	  of	  activating	  receptors	   and	   have	   demonstrated	   potential	   to	   partly	   overcome	   KIR-­‐HLA	   inhibition	  (162).	  This	  will	  lead	  to	  either	  direct	  lysis	  by	  the	  NK	  cells	  or	  recruitment	  and	  activation	  of	  T	  cells.	  Regardless	  of	  how	  GVHD	  was	  induced	  in	  the	  patients,	  this	  study	  emphasizes	  the	  need	  to	  carefully	  consider	  the	  potential	  of	  NK	  cells	  as	  mediators	  for	  GVHD.	  	  The	  in	  vitro	  expanded	  adaptive	  NK	  cells	  discussed	  in	  paper	  IV	  show	  high	  specificity	  and	  remain	  tolerant	  to	  cells	  expressing	  self-­‐HLA	  despite	  the	  two-­‐week	  culture	  in	  IL-­‐15.	  This	  property	  makes	   them	  attractive	   in	   the	   context	  of	   immunotherapy	  against	  HLA	  class	   I	  low/negative	  tumors,	  since	  one	  can	  expect	  minimal	  off-­‐target	  toxicity	  if	  the	  recipient	  is	  matched	   with	   respect	   to	   HLA	   class	   I.	   Numerous	   clinical	   trials	   and	   FDA	   approved	  immunotherapies	  using	  checkpoint	  inhibitors	  to	  enhance	  T	  cell	  function	  are	  in	  use.	  As	  the	  tumors	  are	  put	  under	  immunological	  pressure	  by	  T	  cells,	  the	  survival	  of	  tumors	  that	  have	  found	  mechanisms	  to	  escape	  T	  cell	   immunity	  will	  be	  promoted.	  Many	  reports	  of	  tumor	  resistance	  occurring	  after	  immunotherapy	  have	  been	  published.	  A	  recent	  study	  of	   melanoma	   patients	   receiving	   PD-­‐1	   blockade	   reported	   the	   occurrence	   of	   several	  mechanisms	   of	   resistance	   (163).	   One	   mechanism	   of	   acquired	   immune	   resistance	  described	  is	  the	  mutation	  and	  loss	  of	  β2m,	  which	  is	  an	  important	  component	  of	  the	  MHC	  class	  I	  molecule.	  The	  loss	  of	  β2m	  in	  the	  patients	  leads	  to	  loss	  of	  HLA	  class	  I	  on	  the	  cell	  surface.	  In	  other	  words,	  the	  cells	   lose	  their	  ability	  to	  present	  antigens,	  resulting	  in	  the	  escape	  from	  T	  cells.	  As	  NK	  cells	  usually	   lyse	  cells	   lacking	  HLA	  class	  I	  one	  would	  think	  that	   they	   would	   compensate	   for	   the	   T	   cell	   resistance.	   However,	   melanoma	   patients	  receiving	  immunotherapy	  and	  acquiring	  resistance	  have	  very	  poor	  prognosis,	  indicating	  that	   the	  patient’s	  NK	  cells	  are	  not	  efficient	  enough	  to	  eliminate	   the	   tumor	  cells	   (164).	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Whether	   this	   is	   due	   to	   hypofunctional	   NK	   cells	   or	   if	   the	   tumors	   have	   acquired	  mechanisms	   to	   escape	   NK	   cell	   cytotoxicity	   remains	   to	   be	   determined.	   Regardless	   of	  which,	   it	   is	   tempting	   to	   think	   that	   the	   highly	   cytotoxic	   expanded	   adaptive	   NK	   cells	  described	   in	   paper	   IV	   might	   overcome	   tumor	   resistance	   and	   be	   used	   as	   a	   rescue	  therapy	  for	  patients	  that	  fail	  on	  conventional	  immunotherapy.	  	  Another	   limiting	   factor	   in	   allogeneic	   NK	   cell	   therapy	   is	   the	   rejection	   of	   the	   graft.	   In	  clinical	   trials	   transferring	   NK	   cells,	   it	   seems	   like	   the	   T	   cells	   get	   highly	   activated	   and	  potentially	  rejects	  the	  graft	  before	  the	  NK	  cells	  are	  able	  to	  clear	  the	  tumors	  (Malmberg	  and	  Björklund,	  unpublished	  observations).	  To	  avoid	  this	  problem,	  autologous	  NK	  cells	  could	  be	   expanded	  and	  used	  against	   tumors	   lacking	  or	   expressing	   low	   levels	   of	  MHC	  class	   I.	   Attempts	   are	   also	   being	  made	   to	   generate	   off-­‐the-­‐shelf	  NK	   cell	   products	  with	  reduced	  levels	  of	  HLA	  class	  I.	  Although	  this	  may	  certainly	  improve	  in	  vivo	  engraftment	  of	  allogeneic	  NK	  cells,	  a	  concern	  is	  that	  they	  will	  downtune	  their	  function	  in	  the	  absence	  of	  HLA	  during	  ex	  vivo	  expansion	  or	  in	  vivo.	  Indeed,	  Landtwing	  et	  al.	  demonstrate	  in	  mice	  with	  reconstituted	  human	  immune	  system	  components	  (huNSG	  mice),	  that	  transfer	  of	  a	  mix	  of	  cells	  from	  two	  donors	  with	  disparate	  HLA-­‐types	  abrogated	  the	  NK	  cell	  education	  process	   in	   the	  recipient	  during	  reconstitution.	  While	  single	  reconstituted	  huNSG	  mice	  displayed	  similar	  functionality	  of	  2DL1+,	  2DL3+	  and	  3DL1+	  NK	  cells	  in	  HLA-­‐C2,	  -­‐C1	  and	  Bw4	   reconstituted	   animals	   respectively	   as	   compared	   to	   the	   controls,	   the	   presence	   of	  noncognate	  HLA	  in	  mixed	  reconstituted	  mice	  resulted	  in	  loss	  of	  education	  regardless	  of	  the	   donor	   ratio	   (165).	   Furthermore,	   Hsu	   and	   colleagues	   showed	   that	   knockdown	   of	  β2m	   (leading	   to	   loss	   of	   self-­‐HLA	   class	   I	   molecules)	   on	   primary	   NK	   cells	   reduce	   the	  responsiveness	   in	   previously	   educated	   NK	   cells	   resulting	   in	   similar	   responses	   as	  uneducated	  NK	  cells	  (166).	  Together	  these	  studies	  demonstrate	  the	  importance	  of	  self-­‐HLA	  presentation	  to	  maintain	  NK	  cell	  function.	  	  One	  major	   concern	   for	   the	   use	   of	  NK	   cell	   therapy	  has	   been	   the	   difficulty	   to	   generate	  large	   numbers	   of	   NK	   cells	   for	   transfusion.	   Today,	   IL-­‐15	   and	   IL-­‐2	   are	   two	   common	  cytokines	  used	  in	  therapeutic	  settings	  as	  they	  promote	  NK	  cell	  expansion	  and	  survival	  both	  in	  vivo	  and	  ex	  vivo	  (167).	  One	  limiting	  factor	  for	  achieving	  good	  NK	  cell	  expansion	  is	  the	  loss	  of	  proliferative	  capacity	  due	  to	  shortening	  of	  telomere	  length	  after	  several	  cell	  divisions	   over	   time	   (168).	   To	   overcome	   this,	   Lee	   and	   colleagues	   established	   an	  expansion	  protocol	  using	   genetically	   engineered	  K562	   cell	   line	   expressing	  membrane	  bound	   IL-­‐21.	   The	   use	   of	  membrane	   bound	   IL-­‐21	   enhanced	   NK	   cell	   proliferation	   and	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generated,	   to	   date,	   the	   highest	   fold-­‐expansion	   of	   pure	   NK	   cells	   without	   sign	   of	  senescence	  or	  telomere	  shortening	  despite	  6	  weeks	  of	  culture	  (154).	  These	  findings	  are	  of	  particular	  importance	  for	  the	  work	  discussed	  in	  paper	  IV.	  Although	  we	  demonstrate	  the	   possibility	   to	   specifically	   expand	   highly	   cytotoxic	   adaptive	   NK	   cells	   expressing	   a	  single	   self-­‐KIR,	   we	   were	   unable	   to	   generate	   large	   numbers	   of	   NK	   cells	   using	   this	  protocol.	   Thus,	   a	   key	   challenge	   is	   to	   combine	   the	   use	   of	   protocols	   that	   selectively	  expand	   the	   desired	   cell	   populations	   to	   large	   numbers	   without	   inducing	   cellular	  senescence.	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4 CONCLUDING REMARKS 
 This	   thesis	   provides	   new	   insights	   into	   the	   biology	   and	   therapeutic	   potential	   of	  “adaptive”	   NK	   cells.	   The	   key	   findings	   presented	   in	   the	   four	   papers	   are	   summarized	  below.	  	  	  
§ Clonal-­‐like	  expansions	  of	  NK	  cells	  occur	  in	  response	  to	  HCMV	  infection	  and	  cause	  a	  stable	  imprint	  in	  the	  KIR	  repertoire	  in	  healthy	  humans.	  	  
§ NK	   cell	   education	   via	   self-­‐specific	   inhibitory	   KIR	   promotes	   the	   expansion	   of	  adaptive	  NK	  cells.	  	  
§ Adaptive	   NK	   cells	   display	   a	   mature	   phenotype	   together	   with	   superior	   IFN-­‐γ	  production	  in	  response	  to	  ADCC.	  
§ KIR	  gene	  copy	  number	  correlates	  linearly	  with	  KIR	  expression	  at	  the	  repertoire	  level,	  influencing	  NK	  cell	  education.	  	  
§ KIR	  gene	  copy	  number	  does	  not	  affect	  the	  emergence	  of	  adaptive	  NK	  cells	  or	  NK	  cell	  education	  at	  the	  single	  cell	  level.	  
§ NKG2C-­‐/-­‐	  humans	  are	  able	  to	  mount	  adaptive	  NK	  cell	  responses	  in	  the	  absence	  of	  both	   activating	   KIRs	   and	   NKG2C,	   revealing	   redundant	   drivers	   of	   adaptive	   NK	  cells	  where	  CD2	  co-­‐stimulation	  plays	  an	  important	  role.	  
§ CD2	  can	  synergize	  with	  both	  NKG2C	  and	  CD16,	  potentially	  acting	  as	  “signal	  2”	  in	  NK	  cell	  activation.	  	  
§ A	   homogeneous	   group	   of	   NKG2C+self-­‐KIR+	   NK	   cells	   can	   be	   expanded	   in	   vitro	  through	  stimulation	  with	  IL-­‐15	  together	  with	  target	  cells	  expressing	  HLA-­‐E	  over	  two	  weeks	  culture.	  
§ The	   in	  vitro	  expanded	  NK	  cells	  display	  high	  cytotoxic	  activity,	  efficiently	  killing	  mismatched	   primary	   ALL	   blasts	   derived	   from	   children.	   The	   NK	   cells	   work	  primarily	   through	   the	  missing-­‐self	   mechanism	   and	   ligation	   through	   NKG2C	   is	  redundant.	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NK	  cell-­‐based	  immunotherapy	  –	  future	  challenges	  
	  Although	  promising	  results	  holds	  for	  the	  future	  of	  NK	  cell-­‐based	  immunotherapy,	  there	  are	  still	  many	  problems	  that	  need	  to	  be	  dealt	  with,	  some	  of	  which	  have	  previously	  been	  discussed	  in	  this	  thesis.	  Listed	  below	  are	  some	  bottlenecks	  that	  need	  to	  be	  overcome	  in	  the	  future.	  	  	  
§ We	   still	   have	   incomplete	   mechanistic	   insights	   into	   the	   regulation	   of	   NK	   cell	  development,	  differentiation,	  homing	  and	  function.	  	  
§ Donor	  variability	  in	  NK	  cell	  repertoires	  influences	  the	  outcome	  of	  in	  terms	  of	  the	  size	   of	   the	   alloreactive	   NK	   cell	   subset	   and	   absolute	   numbers	   of	   NK	   cells	  generated	  for	  therapeutic	  use.	  	  
§ Strategies	  to	  generate	  large	  numbers	  of	  selected	  NK	  cell	  subsets	  for	  off-­‐the-­‐shelf	  NK	  cell	  products.	  
§ Inter-­‐species	   differences	   remains	   a	   major	   problem	   for	   developing	   suitable	  animal	  models	  for	  evaluating	  NK	  cell	  toxicity	  and	  efficacy.	  
§ The	  high	  cost	  for	  pre-­‐clinical	  validation	  studies	  and	  phase	  I/II	  trials	  as	  well	  as	  for	  producing	  NK	  cell	  products	  in	  a	  GMP	  environment.	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